data-cut-off-date,web-posting-date,aesi-category,aesi,pfizer-events,moderna-events,cov-azc-events,unspecified-events,total-events,pfizer-rate,moderna-rate,cov-azc-rate,total-rate
2021-05-14,2021-05-21,Auto-immune diseases,Guillain-Barré Syndrome,7,0,6,0,13,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Auto-immune diseases,Thrombocytopenia (low blood platelets),6,1,15,0,22,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Auto-immune diseases,Subtotal n (%),13,1,21,0,35,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Cardiovascular system,Cardiac arrest,3,5,1,0,9,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Cardiovascular system,Cardiac failure,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Cardiovascular system,Microangiopathy,0,0,0,0,0,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Cardiovascular system,Myocardial infarction (heart attack),8,4,3,0,15,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Cardiovascular system,Myocarditis (heart inflammation),12,2,1,0,15,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Cardiovascular system,Stress cardiomyopathy,0,0,0,0,0,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Cardiovascular system,Subtotal n (%),24,11,5,0,40,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Circulatory system,Cerebral venous (sinus) thrombosis,0,0,4,0,4,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Circulatory system,Cerebral thrombosis,0,1,2,0,3,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Circulatory system,Cutaneous vasculitis,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Circulatory system,Deep vein thrombosis,13,6,17,0,36,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Circulatory system,Embolism,0,0,2,0,2,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Circulatory system,Haemorrhage (bleeding),3,2,1,0,6,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Circulatory system,Pulmonary embolism,31,9,35,0,75,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Circulatory system,Thrombosis (blood clot),14,1,21,3,39,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),0,0,22,0,22,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Circulatory system,Subtotal n (%),62,19,104,3,188,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Hepato-gastrointestinal and renal system,Acute kidney injury,7,1,0,0,8,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Hepato-gastrointestinal and renal system,Liver injury,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Hepato-gastrointestinal and renal system,Subtotal n (%),8,1,0,0,9,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Nerves and central nervous system,Bell's Palsy/Facial Paralysis,93,27,11,0,131,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Nerves and central nervous system,Cerebrovascular accident (stroke),28,4,13,1,46,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Nerves and central nervous system,Generalized convulsion (seizure),0,0,0,0,0,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),4,2,0,0,6,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Nerves and central nervous system,Subtotal n (%),125,33,24,1,183,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Other system,Anaphylaxis,53,9,0,0,62,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Other system,COVID-19*,55,0,1,0,56,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Other system,Subtotal n (%),108,9,1,0,118,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Pregnancy outcomes,Fetal growth restriction,3,0,0,0,3,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Pregnancy outcomes,Spontaneous abortion,3,0,0,0,3,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Pregnancy outcomes,Subtotal n (%),6,0,0,0,6,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Respiratory system,Acute respiratory distress syndrome,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,Respiratory system,Subtotal n (%),1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,"Skin and mucous membrane, bone and joints system",Chilblains,3,0,0,0,3,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),2,1,1,0,4,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,"Skin and mucous membrane, bone and joints system",Subtotal n (%),5,1,1,0,7,N/A,N/A,N/A,N/A
2021-05-14,2021-05-21,All AESI categories ,TOTAL,352,75,156,4,587,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Auto-immune diseases,Guillain-Barré Syndrome,7,0,8,0,15,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Auto-immune diseases,Thrombocytopenia (low blood platelets),6,1,12,0,19,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Auto-immune diseases,Subtotal n (%),13,1,20,0,34,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Cardiovascular system,Cardiac arrest,4,5,1,0,10,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Cardiovascular system,Cardiac failure,3,0,0,0,3,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Cardiovascular system,Microangiopathy,0,0,0,0,0,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Cardiovascular system,Myocardial infarction (heart attack),11,5,3,0,18,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),18,3,2,0,23,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Cardiovascular system,Stress cardiomyopathy,0,0,0,0,0,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Cardiovascular system,Subtotal n (%),36,13,6,0,54,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Circulatory system,Cerebral venous (sinus) thrombosis,1,0,4,0,5,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Circulatory system,Cerebral thrombosis ,0,1,2,0,3,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Circulatory system,Cutaneous vasculitis,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Circulatory system,Deep vein thrombosis,17,7,19,0,43,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Circulatory system,Embolism,1,0,3,0,4,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Circulatory system,Haemorrhage (bleeding),3,3,1,0,7,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Circulatory system,Pulmonary embolism,34,13,40,0,86,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Circulatory system,Thrombosis (blood clot),19,1,23,3,46,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),0,0,33,0,33,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Circulatory system,Subtotal n (%),76,25,125,3,228,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Hepato-gastrointestinal and renal system,Acute kidney injury,7,2,0,0,8,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Hepato-gastrointestinal and renal system,Liver injury,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Hepato-gastrointestinal and renal system,Subtotal n (%),8,2,0,0,9,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Nerves and central nervous system,Bell's Palsy/Facial paralysis,105,27,15,0,147,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Nerves and central nervous system,Cerebrovascular accident (stroke),29,4,13,1,47,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Nerves and central nervous system,Generalized convulsion (seizure),0,0,0,0,0,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),4,2,0,0,6,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Nerves and central nervous system,Subtotal n (%),138,33,28,1,200,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Other system,Anaphylaxis,59,10,0,0,69,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Other system,COVID-19*,55,0,1,0,56,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Other system,Subtotal n (%),114,10,1,0,125,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Pregnancy outcomes,Fetal growth restriction,3,0,0,0,3,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Pregnancy outcomes,Spontaneous abortion,7,1,0,0,8,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Pregnancy outcomes,Subtotal n (%),10,1,0,0,11,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Respiratory system,Acute respiratory distress syndrome,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,Respiratory system,Subtotal n (%),1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,"Skin and mucous membrane, bone and joints system",Chilblains,3,0,0,0,3,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),2,2,1,0,5,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,"Skin and mucous membrane, bone and joints system",Subtotal n (%),5,2,1,0,8,N/A,N/A,N/A,N/A
2021-05-21,2021-05-28,All AESI categories ,TOTAL,401,87,181,4,673,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Auto-immune diseases,Guillain-Barré Syndrome,3,0,8,0,11,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Auto-immune diseases,Thrombocytopenia (low blood platelets),10,1,19,0,30,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Auto-immune diseases,Subtotal n (%),13,1,27,0,41,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Cardiovascular system,Cardiac arrest,4,6,1,0,11,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Cardiovascular system,Cardiac failure,4,0,1,0,5,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Cardiovascular system,Myocardial infarction (heart attack),14,7,3,0,24,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),19,4,2,0,25,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Cardiovascular system,Subtotal n (%),41,17,7,0,65,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Circulatory system,Cerebral venous (sinus) thrombosis,1,0,6,0,7,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Circulatory system,Cerebral thrombosis ,0,1,2,0,3,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Circulatory system,Cutaneous vasculitis,2,1,0,0,3,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Circulatory system,Deep vein thrombosis,20,8,25,0,53,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Circulatory system,Embolism,1,0,3,0,4,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Circulatory system,Haemorrhage (bleeding),4,5,2,0,11,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Circulatory system,Pulmonary embolism,39,15,48,0,102,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Circulatory system,Thrombosis (blood clot),20,1,24,3,48,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),1,1,42,0,44,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Circulatory system,Subtotal n (%),88,32,152,3,275,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Hepato-gastrointestinal and renal system,Acute kidney injury,9,3,0,0,12,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Hepato-gastrointestinal and renal system,Liver injury,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Hepato-gastrointestinal and renal system,Subtotal n (%),10,3,0,0,13,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Nerves and central nervous system,Bell's Palsy/Facial paralysis,111,31,19,0,161,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Nerves and central nervous system,Cerebrovascular accident (stroke),32,4,19,2,57,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),4,2,0,0,6,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Nerves and central nervous system,Subtotal n (%),147,37,38,2,224,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Other system,Anaphylaxis,57,12,0,0,69,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Other system,COVID-19*,60,1,2,0,63,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Other system,Subtotal n (%),117,13,2,0,132,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Pregnancy outcomes,Fetal growth restriction,2,0,0,0,2,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Pregnancy outcomes,Spontaneous abortion,7,2,0,0,9,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Pregnancy outcomes,Subtotal n (%),9,2,0,0,11,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Respiratory system,Acute respiratory distress syndrome,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,Respiratory system,Subtotal n (%),1,0,0,0,1,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,"Skin and mucous membrane, bone and joints system",Chilblains,3,0,0,0,3,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),4,2,1,0,7,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,"Skin and mucous membrane, bone and joints system",Subtotal n (%),7,2,1,0,10,N/A,N/A,N/A,N/A
2021-05-28,2021-06-04,All AESI categories ,TOTAL,433,107,227,5,772,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Auto-immune diseases,Guillain-Barré Syndrome,4,0,9,0,13,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Auto-immune diseases,Thrombocytopenia (low blood platelets),10,1,23,0,34,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Auto-immune diseases,Subtotal n (%),14,1,32,0,47,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Cardiovascular system,Cardiac arrest,4,6,3,0,13,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Cardiovascular system,Cardiac failure,5,0,1,0,6,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Cardiovascular system,Myocardial infarction (heart attack),14,7,5,0,26,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),25,6,3,1,35,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Cardiovascular system,Subtotal n (%),48,19,12,1,80,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Circulatory system,Cerebral venous (sinus) thrombosis,1,0,8,0,9,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Circulatory system,Cerebral thrombosis ,0,1,2,0,3,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Circulatory system,Cutaneous vasculitis,2,1,0,0,3,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Circulatory system,Deep vein thrombosis,20,8,27,0,55,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Circulatory system,Embolism,1,0,3,0,4,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Circulatory system,Haemorrhage (bleeding),4,6,3,0,13,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Circulatory system,Pulmonary embolism,45,17,59,1,122,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Circulatory system,Thrombosis (blood clot),29,1,37,4,71,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),3,1,46,0,50,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Circulatory system,Subtotal n (%),105,35,185,5,330,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Hepato-gastrointestinal and renal system,Acute kidney injury,9,3,0,0,12,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Hepato-gastrointestinal and renal system,Liver injury,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Hepato-gastrointestinal and renal system,Subtotal n (%),10,3,0,0,13,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Nerves and central nervous system,Bell's Palsy/Facial paralysis,117,35,24,0,176,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Nerves and central nervous system,Cerebrovascular accident (stroke),35,4,19,2,60,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),4,2,1,0,7,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Nerves and central nervous system,Subtotal n (%),156,41,44,2,243,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Other system,Anaphylaxis,60,12,0,0,72,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Other system,COVID-19*,66,1,2,0,69,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Other system,Subtotal n (%),126,13,2,0,141,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Pregnancy outcomes,Fetal growth restriction,3,0,0,0,3,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Pregnancy outcomes,Spontaneous abortion,9,2,0,0,11,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Pregnancy outcomes,Subtotal n (%),12,2,0,0,14,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Respiratory system,Acute respiratory distress syndrome,1,0,0,0,1,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,Respiratory system,Subtotal n (%),1,0,0,0,1,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,"Skin and mucous membrane, bone and joints system",Chilblains,3,0,0,0,3,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),4,2,1,0,7,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,"Skin and mucous membrane, bone and joints system",Subtotal n (%),7,2,1,0,10,N/A,N/A,N/A,N/A
2021-06-04,2021-06-11,All AESI categories ,TOTAL,479,116,276,8,879,N/A,N/A,N/A,N/A
2021-06-11,2021-06-18,Auto-immune diseases,Guillain-Barré Syndrome,8,2,13,0,23,0.04,0.04,0.52,0.08
2021-06-11,2021-06-18,Auto-immune diseases,Thrombocytopenia (low blood platelets),10,2,29,0,41,0.05,0.04,1.17,0.14
2021-06-11,2021-06-18,Auto-immune diseases,Subtotal n (%),18,4,42,0,64,0.08,0.07,1.70,0.22
2021-06-11,2021-06-18,Cardiovascular system,Cardiac arrest,4,7,5,0,16,0.02,0.13,0.20,0.05
2021-06-11,2021-06-18,Cardiovascular system,Cardiac failure,7,0,2,0,9,0.03,0.00,0.08,0.03
2021-06-11,2021-06-18,Cardiovascular system,Myocardial infarction (heart attack),16,7,5,0,28,0.08,0.13,0.20,0.10
2021-06-11,2021-06-18,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),40,8,4,1,53,0.19,0.15,0.16,0.18
2021-06-11,2021-06-18,Cardiovascular system,Subtotal n (%),67,22,16,1,106,0.31,0.40,0.65,0.36
2021-06-11,2021-06-18,Circulatory system,Cerebral venous (sinus) thrombosis,2,0,9,0,11,0.01,0.00,0.36,0.04
2021-06-11,2021-06-18,Circulatory system,Cerebral thrombosis ,1,1,2,0,4,0.00,0.02,0.08,0.01
2021-06-11,2021-06-18,Circulatory system,Cutaneous vasculitis,2,2,0,1,5,0.01,0.04,0.00,0.02
2021-06-11,2021-06-18,Circulatory system,Deep vein thrombosis,31,12,32,1,76,0.15,0.22,1.29,0.26
2021-06-11,2021-06-18,Circulatory system,Embolism,1,0,4,0,5,0.00,0.00,0.16,0.02
2021-06-11,2021-06-18,Circulatory system,Haemorrhage (bleeding),5,6,4,0,15,0.02,0.11,0.16,0.05
2021-06-11,2021-06-18,Circulatory system,Pulmonary embolism,51,18,69,1,139,0.24,0.33,2.79,0.47
2021-06-11,2021-06-18,Circulatory system,Thrombosis (blood clot),36,1,51,4,92,0.17,0.02,2.06,0.31
2021-06-11,2021-06-18,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),3,0,52,0,55,0.01,0.00,2.10,0.19
2021-06-11,2021-06-18,Circulatory system,Subtotal n (%),132,40,223,7,402,0.62,0.73,9.00,1.37
2021-06-11,2021-06-18,Hepato-gastrointestinal and renal system,Acute kidney injury,10,3,1,0,14,0.05,0.05,0.04,0.05
2021-06-11,2021-06-18,Hepato-gastrointestinal and renal system,Liver injury,2,1,0,0,3,0.01,0.02,0.00,0.01
2021-06-11,2021-06-18,Hepato-gastrointestinal and renal system,Subtotal n (%),12,4,1,0,17,0.06,0.07,0.04,0.06
2021-06-11,2021-06-18,Nerves and central nervous system,Bell's Palsy,91,20,14,12,137,0.43,0.37,0.57,0.47
2021-06-11,2021-06-18,Nerves and central nervous system,Cerebrovascular accident (stroke),37,4,21,2,64,0.17,0.07,0.85,0.22
2021-06-11,2021-06-18,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),5,2,2,0,9,0.02,0.04,0.08,0.03
2021-06-11,2021-06-18,Nerves and central nervous system,Subtotal n (%),133,26,37,14,210,0.62,0.48,1.49,0.72
2021-06-11,2021-06-18,Other system,Anaphylaxis,63,13,0,0,76,0.30,0.24,0.00,0.26
2021-06-11,2021-06-18,Other system,COVID-19*,83,1,2,0,86,0.39,0.02,0.08,0.29
2021-06-11,2021-06-18,Other system,Subtotal n (%),146,14,2,0,162,0.69,0.26,0.08,0.55
2021-06-11,2021-06-18,Pregnancy outcomes,Fetal growth restriction,3,0,0,0,3,0.01,0.00,0.00,0.01
2021-06-11,2021-06-18,Pregnancy outcomes,Spontaneous abortion,10,2,0,0,12,0.05,0.04,0.00,0.04
2021-06-11,2021-06-18,Pregnancy outcomes,Subtotal n (%),13,2,0,0,15,0.06,0.04,0.00,0.05
2021-06-11,2021-06-18,Respiratory system,Acute respiratory distress syndrome,1,0,0,0,1,0.00,0.00,0.00,0.00
2021-06-11,2021-06-18,Respiratory system,Subtotal n (%),1,0,0,0,1,0.00,0.00,0.00,0.00
2021-06-11,2021-06-18,"Skin and mucous membrane, bone and joints system",Chilblains,4,0,0,0,4,0.02,0.00,0.00,0.01
2021-06-11,2021-06-18,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),4,2,1,0,7,0.02,0.04,0.04,0.02
2021-06-11,2021-06-18,"Skin and mucous membrane, bone and joints system",Subtotal n (%),8,2,1,0,11,0.04,0.04,0.04,0.04
2021-06-11,2021-06-18,All AESI categories ,TOTAL,530,114,322,22,988,2.49,2.08,13.00,3.38
2021-06-18,2021-06-25,Auto-immune diseases,Guillain-Barré Syndrome,10,2,16,0,28,0.04,0.03,0.62,0.09
2021-06-18,2021-06-25,Auto-immune diseases,Thrombocytopenia (low blood platelets),11,2,34,0,47,0.05,0.03,1.31,0.15
2021-06-18,2021-06-25,Auto-immune diseases,Subtotal n (%),21,4,50,0,75,0.09,0.07,1.93,0.23
2021-06-18,2021-06-25,Cardiovascular system,Cardiac arrest,5,7,5,0,17,0.02,0.12,0.19,0.05
2021-06-18,2021-06-25,Cardiovascular system,Cardiac failure,7,0,2,0,9,0.03,0.00,0.08,0.03
2021-06-18,2021-06-25,Cardiovascular system,Myocardial infarction (heart attack),18,7,5,0,30,0.08,0.12,0.19,0.09
2021-06-18,2021-06-25,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),50,10,5,0,65,0.21,0.17,0.19,0.20
2021-06-18,2021-06-25,Cardiovascular system,Subtotal n (%),80,24,17,0,121,0.34,0.40,0.65,0.37
2021-06-18,2021-06-25,Circulatory system,Cerebral venous (sinus) thrombosis,2,0,10,0,12,0.01,0.00,0.39,0.04
2021-06-18,2021-06-25,Circulatory system,Cerebral thrombosis ,1,1,2,0,4,0.00,0.02,0.08,0.01
2021-06-18,2021-06-25,Circulatory system,Cutaneous vasculitis,2,1,0,0,3,0.01,0.02,0.00,0.01
2021-06-18,2021-06-25,Circulatory system,Deep vein thrombosis,35,13,35,1,84,0.15,0.22,1.35,0.26
2021-06-18,2021-06-25,Circulatory system,Embolism,2,0,5,0,7,0.01,0.00,0.19,0.02
2021-06-18,2021-06-25,Circulatory system,Haemorrhage (bleeding),7,6,4,0,17,0.03,0.10,0.15,0.05
2021-06-18,2021-06-25,Circulatory system,Pulmonary embolism,59,23,73,1,156,0.25,0.38,2.81,0.48
2021-06-18,2021-06-25,Circulatory system,Thrombosis (blood clot),38,4,59,4,105,0.16,0.07,2.27,0.32
2021-06-18,2021-06-25,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),3,1,54,0,58,0.01,0.02,2.08,0.18
2021-06-18,2021-06-25,Circulatory system,Subtotal n (%),149,49,242,6,446,0.63,0.82,9.32,1.38
2021-06-18,2021-06-25,Hepato-gastrointestinal and renal system,Acute kidney injury,11,3,1,0,15,0.05,0.05,0.04,0.05
2021-06-18,2021-06-25,Hepato-gastrointestinal and renal system,Liver injury,2,1,0,0,3,0.01,0.02,0.00,0.01
2021-06-18,2021-06-25,Hepato-gastrointestinal and renal system,Subtotal n (%),13,4,1,0,18,0.05,0.07,0.04,0.06
2021-06-18,2021-06-25,Nerves and central nervous system,Bell's Palsy,110,32,22,0,164,0.46,0.53,0.85,0.51
2021-06-18,2021-06-25,Nerves and central nervous system,Cerebrovascular accident (stroke),42,6,21,2,71,0.18,0.10,0.81,0.22
2021-06-18,2021-06-25,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),6,2,2,0,10,0.03,0.03,0.08,0.03
2021-06-18,2021-06-25,Nerves and central nervous system,Subtotal n (%),158,40,45,2,245,0.66,0.67,1.73,0.76
2021-06-18,2021-06-25,Other system,Anaphylaxis,70,13,0,0,83,0.29,0.22,0.00,0.26
2021-06-18,2021-06-25,Other system,COVID-19*,83,1,2,0,86,0.35,0.02,0.08,0.27
2021-06-18,2021-06-25,Other system,Subtotal n (%),153,14,2,0,169,0.64,0.23,0.08,0.52
2021-06-18,2021-06-25,Pregnancy outcomes,Fetal growth restriction,3,0,0,0,3,0.01,0.00,0.00,0.01
2021-06-18,2021-06-25,Pregnancy outcomes,Spontaneous abortion,11,2,0,0,13,0.05,0.03,0.00,0.04
2021-06-18,2021-06-25,Pregnancy outcomes,Subtotal n (%),14,2,0,0,16,0.06,0.03,0.00,0.05
2021-06-18,2021-06-25,Respiratory system,Acute respiratory distress syndrome,1,0,0,0,1,0.00,0.00,0.00,0.00
2021-06-18,2021-06-25,Respiratory system,Subtotal n (%),1,0,0,0,1,0.00,0.00,0.00,0.00
2021-06-18,2021-06-25,"Skin and mucous membrane, bone and joints system",Chilblains,5,0,0,0,5,0.02,0.00,0.00,0.02
2021-06-18,2021-06-25,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),5,3,1,0,9,0.02,0.05,0.04,0.03
2021-06-18,2021-06-25,"Skin and mucous membrane, bone and joints system",Subtotal n (%),10,3,1,0,14,0.04,0.05,0.04,0.04
2021-06-18,2021-06-25,All AESI categories ,TOTAL,599,140,358,8,1105,2.52,2.34,13.79,3.41
2021-06-25,2021-07-05,Auto-immune diseases,Guillain-Barré Syndrome,11,3,17,1,32,0.05,0.05,0.65,0.10
2021-06-25,2021-07-05,Auto-immune diseases,Thrombocytopenia (low blood platelets),12,3,33,0,48,0.05,0.05,1.27,0.15
2021-06-25,2021-07-05,Auto-immune diseases,Subtotal n (%),23,6,50,1,80,0.10,0.10,1.93,0.25
2021-06-25,2021-07-05,Cardiovascular system,Cardiac arrest,6,7,5,0,18,0.03,0.12,0.19,0.06
2021-06-25,2021-07-05,Cardiovascular system,Cardiac failure,8,0,2,0,10,0.03,0.00,0.08,0.03
2021-06-25,2021-07-05,Cardiovascular system,Myocardial infarction (heart attack),19,7,4,0,30,0.08,0.12,0.15,0.09
2021-06-25,2021-07-05,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),64,18,7,1,90,0.27,0.30,0.27,0.28
2021-06-25,2021-07-05,Cardiovascular system,Subtotal n (%),97,32,18,1,148,0.41,0.53,0.69,0.46
2021-06-25,2021-07-05,Circulatory system,Cerebral venous (sinus) thrombosis,2,0,10,0,12,0.01,0.00,0.39,0.04
2021-06-25,2021-07-05,Circulatory system,Cerebral thrombosis ,1,1,2,0,4,0.00,0.02,0.08,0.01
2021-06-25,2021-07-05,Circulatory system,Cutaneous vasculitis,2,3,0,0,5,0.01,0.05,0.00,0.02
2021-06-25,2021-07-05,Circulatory system,Deep vein thrombosis,37,14,39,1,91,0.16,0.23,1.50,0.28
2021-06-25,2021-07-05,Circulatory system,Embolism,2,1,5,0,8,0.01,0.02,0.19,0.02
2021-06-25,2021-07-05,Circulatory system,Haemorrhage (bleeding),7,6,4,0,17,0.03,0.10,0.15,0.05
2021-06-25,2021-07-05,Circulatory system,Pulmonary embolism,65,24,79,1,169,0.27,0.40,3.04,0.52
2021-06-25,2021-07-05,Circulatory system,Thrombosis (blood clot),41,4,59,4,108,0.17,0.07,2.27,0.33
2021-06-25,2021-07-05,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),3,1,55,0,59,0.01,0.02,2.12,0.18
2021-06-25,2021-07-05,Circulatory system,Subtotal n (%),160,54,253,6,473,0.67,0.90,9.74,1.46
2021-06-25,2021-07-05,Hepato-gastrointestinal and renal system,Acute kidney injury,12,3,1,0,16,0.05,0.05,0.04,0.05
2021-06-25,2021-07-05,Hepato-gastrointestinal and renal system,Liver injury,3,1,0,0,4,0.01,0.02,0.00,0.01
2021-06-25,2021-07-05,Hepato-gastrointestinal and renal system,Subtotal n (%),15,4,1,0,20,0.06,0.07,0.04,0.06
2021-06-25,2021-07-05,Nerves and central nervous system,Bell's Palsy,145,41,28,1,215,0.61,0.68,1.08,0.66
2021-06-25,2021-07-05,Nerves and central nervous system,Cerebrovascular accident (stroke),45,7,22,2,76,0.19,0.12,0.85,0.23
2021-06-25,2021-07-05,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),8,2,3,0,13,0.03,0.03,0.12,0.04
2021-06-25,2021-07-05,Nerves and central nervous system,Subtotal n (%),198,50,53,3,304,0.83,0.84,2.04,0.94
2021-06-25,2021-07-05,Other system,Anaphylaxis,72,14,1,0,87,0.30,0.23,0.04,0.27
2021-06-25,2021-07-05,Other system,COVID-19*,84,1,2,0,87,0.35,0.02,0.08,0.27
2021-06-25,2021-07-05,Other system,Subtotal n (%),156,15,3,0,174,0.66,0.25,0.12,0.54
2021-06-25,2021-07-05,Pregnancy outcomes,Fetal growth restriction,4,0,0,0,4,0.02,0.00,0.00,0.01
2021-06-25,2021-07-05,Pregnancy outcomes,Spontaneous abortion,12,3,0,0,15,0.05,0.05,0.00,0.05
2021-06-25,2021-07-05,Pregnancy outcomes,Subtotal n (%),16,3,0,0,19,0.07,0.05,0.00,0.06
2021-06-25,2021-07-05,Respiratory system,Acute respiratory distress syndrome,1,0,0,0,1,0.00,0.00,0.00,0.00
2021-06-25,2021-07-05,Respiratory system,Subtotal n (%),1,0,0,0,1,0.00,0.00,0.00,0.00
2021-06-25,2021-07-05,"Skin and mucous membrane, bone and joints system",Chilblains,5,0,0,0,5,0.02,0.00,0.00,0.02
2021-06-25,2021-07-05,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),6,3,1,0,10,0.03,0.05,0.04,0.03
2021-06-25,2021-07-05,"Skin and mucous membrane, bone and joints system",Subtotal n (%),11,3,1,0,15,0.05,0.05,0.04,0.05
2021-06-25,2021-07-05,All AESI categories ,TOTAL,677,167,379,11,1234,2.85,2.79,14.59,3.81
2021-07-02,2021-07-09,Auto-immune diseases,Guillain-Barré Syndrome,12,4,20,1,37,0.05,0.05,0.75,0.10
2021-07-02,2021-07-09,Auto-immune diseases,Thrombocytopenia (low blood platelets),12,4,33,1,50,0.05,0.05,1.23,0.14
2021-07-02,2021-07-09,Auto-immune diseases,Subtotal n (%),24,8,53,2,87,0.09,0.10,1.97,0.24
2021-07-02,2021-07-09,Cardiovascular system,Cardiac arrest,6,8,5,0,19,0.02,0.10,0.19,0.05
2021-07-02,2021-07-09,Cardiovascular system,Cardiac failure,8,1,2,0,11,0.03,0.01,0.07,0.03
2021-07-02,2021-07-09,Cardiovascular system,Myocardial infarction (heart attack),21,7,5,1,34,0.08,0.09,0.19,0.10
2021-07-02,2021-07-09,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),70,26,8,1,105,0.28,0.34,0.30,0.29
2021-07-02,2021-07-09,Cardiovascular system,Subtotal n (%),105,42,20,2,169,0.41,0.55,0.75,0.47
2021-07-02,2021-07-09,Circulatory system,Cerebral venous (sinus) thrombosis,2,0,10,0,12,0.01,0.00,0.37,0.03
2021-07-02,2021-07-09,Circulatory system,Cerebral thrombosis ,2,1,2,0,5,0.01,0.01,0.07,0.01
2021-07-02,2021-07-09,Circulatory system,Cutaneous vasculitis,2,3,0,0,5,0.01,0.04,0.00,0.01
2021-07-02,2021-07-09,Circulatory system,Deep vein thrombosis,41,18,41,1,101,0.16,0.24,1.53,0.28
2021-07-02,2021-07-09,Circulatory system,Embolism,2,1,5,0,8,0.01,0.01,0.19,0.02
2021-07-02,2021-07-09,Circulatory system,Haemorrhage (bleeding),10,6,5,0,21,0.04,0.08,0.19,0.06
2021-07-02,2021-07-09,Circulatory system,Pulmonary embolism,67,26,81,1,175,0.26,0.34,3.02,0.49
2021-07-02,2021-07-09,Circulatory system,Thrombosis (blood clot),46,4,62,4,116,0.18,0.05,2.31,0.32
2021-07-02,2021-07-09,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),3,1,55,0,59,0.01,0.01,2.05,0.16
2021-07-02,2021-07-09,Circulatory system,Subtotal n (%),175,60,261,6,502,0.69,0.79,9.73,1.40
2021-07-02,2021-07-09,Hepato-gastrointestinal and renal system,Acute kidney injury,11,3,1,0,15,0.04,0.04,0.04,0.04
2021-07-02,2021-07-09,Hepato-gastrointestinal and renal system,Liver injury,3,1,0,0,4,0.01,0.01,0.00,0.01
2021-07-02,2021-07-09,Hepato-gastrointestinal and renal system,Subtotal n (%),14,4,1,0,19,0.06,0.05,0.04,0.05
2021-07-02,2021-07-09,Nerves and central nervous system,Bell's Palsy,158,46,31,1,236,0.62,0.60,1.16,0.66
2021-07-02,2021-07-09,Nerves and central nervous system,Cerebrovascular accident (stroke),48,9,23,2,82,0.19,0.12,0.86,0.23
2021-07-02,2021-07-09,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),8,3,3,0,14,0.03,0.04,0.11,0.04
2021-07-02,2021-07-09,Nerves and central nervous system,Subtotal n (%),214,58,57,3,332,0.84,0.76,2.12,0.93
2021-07-02,2021-07-09,Other system,Anaphylaxis,79,15,0,0,94,0.31,0.20,0.00,0.26
2021-07-02,2021-07-09,Other system,COVID-19*,85,1,2,0,88,0.33,0.01,0.07,0.25
2021-07-02,2021-07-09,Other system,Subtotal n (%),164,16,2,0,182,0.64,0.21,0.07,0.51
2021-07-02,2021-07-09,Pregnancy outcomes,Fetal growth restriction,4,0,0,0,4,0.02,0.00,0.00,0.01
2021-07-02,2021-07-09,Pregnancy outcomes,Spontaneous abortion,12,4,0,0,16,0.05,0.05,0.00,0.04
2021-07-02,2021-07-09,Pregnancy outcomes,Subtotal n (%),16,4,0,0,20,0.06,0.05,0.00,0.06
2021-07-02,2021-07-09,Respiratory system,Acute respiratory distress syndrome,1,0,0,0,1,0.00,0.00,0.00,0.00
2021-07-02,2021-07-09,Respiratory system,Subtotal n (%),1,0,0,0,1,0.00,0.00,0.00,0.00
2021-07-02,2021-07-09,"Skin and mucous membrane, bone and joints system",Chilblains,5,0,0,0,5,0.02,0.00,0.00,0.01
2021-07-02,2021-07-09,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),6,3,1,0,10,0.02,0.04,0.04,0.03
2021-07-02,2021-07-09,"Skin and mucous membrane, bone and joints system",Subtotal n (%),11,3,1,0,15,0.04,0.04,0.04,0.04
2021-07-02,2021-07-09,All AESI categories ,TOTAL,724,195,395,13,1327,2.85,2.56,14.72,3.71
2021-07-09,2021-07-16,Auto-immune diseases,Guillain-Barré Syndrome,14,4,25,0,43,0.05,0.04,0.92,0.11
2021-07-09,2021-07-16,Auto-immune diseases,Thrombocytopenia (low blood platelets),12,4,33,1,50,0.04,0.04,1.21,0.13
2021-07-09,2021-07-16,Auto-immune diseases,Subtotal n (%),26,8,58,1,93,0.09,0.09,2.14,0.24
2021-07-09,2021-07-16,Cardiovascular system,Cardiac arrest,6,8,5,0,19,0.02,0.09,0.18,0.05
2021-07-09,2021-07-16,Cardiovascular system,Cardiac failure,9,2,2,0,13,0.03,0.02,0.07,0.03
2021-07-09,2021-07-16,Cardiovascular system,Myocardial infarction (heart attack),25,8,7,1,41,0.09,0.09,0.26,0.10
2021-07-09,2021-07-16,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),111,40,11,1,163,0.40,0.44,0.40,0.41
2021-07-09,2021-07-16,Cardiovascular system,Subtotal n (%),151,58,25,2,236,0.55,0.64,0.92,0.60
2021-07-09,2021-07-16,Circulatory system,Cerebral venous (sinus) thrombosis,3,0,11,0,14,0.01,0.00,0.40,0.04
2021-07-09,2021-07-16,Circulatory system,Cerebral thrombosis ,2,1,2,0,5,0.01,0.01,0.07,0.01
2021-07-09,2021-07-16,Circulatory system,Cutaneous vasculitis,3,3,0,0,6,0.01,0.03,0.00,0.02
2021-07-09,2021-07-16,Circulatory system,Deep vein thrombosis,49,20,42,0,111,0.18,0.22,1.55,0.28
2021-07-09,2021-07-16,Circulatory system,Embolism,2,1,5,0,8,0.01,0.01,0.18,0.02
2021-07-09,2021-07-16,Circulatory system,Haemorrhage (bleeding),4,6,6,0,16,0.01,0.07,0.22,0.04
2021-07-09,2021-07-16,Circulatory system,Pulmonary embolism,76,28,84,1,189,0.27,0.31,3.09,0.48
2021-07-09,2021-07-16,Circulatory system,Thrombosis (blood clot),49,8,64,2,123,0.18,0.09,2.36,0.31
2021-07-09,2021-07-16,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),3,1,55,0,59,0.01,0.01,2.02,0.15
2021-07-09,2021-07-16,Circulatory system,Subtotal n (%),191,68,269,3,531,0.69,0.75,9.90,1.35
2021-07-09,2021-07-16,Hepato-gastrointestinal and renal system,Acute kidney injury,13,3,1,0,17,0.05,0.03,0.04,0.04
2021-07-09,2021-07-16,Hepato-gastrointestinal and renal system,Liver injury,5,1,1,0,7,0.02,0.01,0.04,0.02
2021-07-09,2021-07-16,Hepato-gastrointestinal and renal system,Subtotal n (%),18,4,2,0,24,0.07,0.04,0.07,0.06
2021-07-09,2021-07-16,Nerves and central nervous system,Bell's Palsy/facial paralysis,173,51,35,1,260,0.63,0.56,1.29,0.66
2021-07-09,2021-07-16,Nerves and central nervous system,Cerebrovascular accident (stroke),52,11,25,2,90,0.19,0.12,0.92,0.23
2021-07-09,2021-07-16,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),9,3,4,0,16,0.03,0.03,0.15,0.04
2021-07-09,2021-07-16,Nerves and central nervous system,Subtotal n (%),234,65,64,3,366,0.85,0.72,2.36,0.93
2021-07-09,2021-07-16,Other system,Anaphylaxis,90,18,0,0,108,0.33,0.20,0.00,0.27
2021-07-09,2021-07-16,Other system,COVID-19*,85,7,6,0,98,0.31,0.08,0.22,0.25
2021-07-09,2021-07-16,Other system,Subtotal n (%),175,25,6,0,206,0.63,0.28,0.22,0.52
2021-07-09,2021-07-16,Pregnancy outcomes,Fetal growth restriction,4,0,0,0,4,0.01,0.00,0.00,0.01
2021-07-09,2021-07-16,Pregnancy outcomes,Spontaneous abortion,14,4,0,0,18,0.05,0.04,0.00,0.05
2021-07-09,2021-07-16,Pregnancy outcomes,Subtotal n (%),18,4,0,0,22,0.07,0.04,0.00,0.06
2021-07-09,2021-07-16,Respiratory system,Acute respiratory distress syndrome,1,0,0,0,1,0.00,0.00,0.00,0.00
2021-07-09,2021-07-16,Respiratory system,Subtotal n (%),1,0,0,0,1,0.00,0.00,0.00,0.00
2021-07-09,2021-07-16,"Skin and mucous membrane, bone and joints system",Chilblains,5,0,0,0,5,0.02,0.00,0.00,0.01
2021-07-09,2021-07-16,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),7,3,1,0,11,0.03,0.03,0.04,0.03
2021-07-09,2021-07-16,"Skin and mucous membrane, bone and joints system",Subtotal n (%),12,3,1,0,16,0.04,0.03,0.04,0.04
2021-07-09,2021-07-16,All AESI categories,TOTAL,826,235,425,9,1495,2.99,2.60,15.64,3.79
2021-07-16,2021-07-23,Auto-immune diseases,Guillain-Barré Syndrome,18,5,25,0,48,0.06,0.05,0.91,0.11
2021-07-16,2021-07-23,Auto-immune diseases,Thrombocytopenia (low blood platelets),15,5,40,1,61,0.05,0.05,1.45,0.14
2021-07-16,2021-07-23,Auto-immune diseases,Subtotal n (%),33,10,65,1,109,0.11,0.10,2.36,0.25
2021-07-16,2021-07-23,Cardiovascular system,Cardiac arrest,7,8,5,0,20,0.02,0.08,0.18,0.05
2021-07-16,2021-07-23,Cardiovascular system,Cardiac failure,9,2,2,0,13,0.03,0.02,0.07,0.03
2021-07-16,2021-07-23,Cardiovascular system,Myocardial infarction (heart attack),30,11,10,1,52,0.10,0.11,0.36,0.12
2021-07-16,2021-07-23,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),132,66,12,1,211,0.45,0.63,0.44,0.49
2021-07-16,2021-07-23,Cardiovascular system,Subtotal n (%),178,87,29,2,296,0.60,0.83,1.05,0.69
2021-07-16,2021-07-23,Circulatory system,Cerebral venous (sinus) thrombosis,3,0,12,0,15,0.01,0.00,0.44,0.04
2021-07-16,2021-07-23,Circulatory system,Cerebral thrombosis ,2,1,2,0,5,0.01,0.01,0.07,0.01
2021-07-16,2021-07-23,Circulatory system,Cutaneous vasculitis,4,3,0,0,7,0.01,0.03,0.00,0.02
2021-07-16,2021-07-23,Circulatory system,Deep vein thrombosis,63,22,49,0,134,0.21,0.21,1.78,0.31
2021-07-16,2021-07-23,Circulatory system,Embolism,2,1,5,0,8,0.01,0.01,0.18,0.02
2021-07-16,2021-07-23,Circulatory system,Haemorrhage (bleeding),12,6,8,0,26,0.04,0.06,0.29,0.06
2021-07-16,2021-07-23,Circulatory system,Pulmonary embolism,84,30,87,1,202,0.28,0.29,3.16,0.47
2021-07-16,2021-07-23,Circulatory system,Thrombosis (blood clot),53,8,63,2,126,0.18,0.08,2.29,0.29
2021-07-16,2021-07-23,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),9,2,56,0,67,0.03,0.02,2.03,0.16
2021-07-16,2021-07-23,Circulatory system,Subtotal n (%),232,73,282,3,590,0.78,0.70,10.24,1.38
2021-07-16,2021-07-23,Hepato-gastrointestinal and renal system,Acute kidney injury,14,4,1,0,19,0.05,0.04,0.04,0.04
2021-07-16,2021-07-23,Hepato-gastrointestinal and renal system,Liver injury,6,1,2,0,9,0.02,0.01,0.07,0.02
2021-07-16,2021-07-23,Hepato-gastrointestinal and renal system,Subtotal n (%),20,5,3,0,28,0.07,0.05,0.11,0.07
2021-07-16,2021-07-23,Nerves and central nervous system,Bell's Palsy/facial paralysis,185,60,35,1,281,0.63,0.57,1.27,0.66
2021-07-16,2021-07-23,Nerves and central nervous system,Cerebrovascular accident (stroke),59,12,29,2,102,0.20,0.11,1.05,0.24
2021-07-16,2021-07-23,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),11,3,4,0,18,0.04,0.03,0.15,0.04
2021-07-16,2021-07-23,Nerves and central nervous system,Subtotal n (%),255,75,68,3,401,0.86,0.72,2.47,0.94
2021-07-16,2021-07-23,Other system,Anaphylaxis,95,19,0,0,114,0.32,0.18,0.00,0.27
2021-07-16,2021-07-23,Other system,COVID-19*,89,2,0,1,92,0.30,0.02,0.00,0.22
2021-07-16,2021-07-23,Other system,Subtotal n (%),184,21,0,1,206,0.62,0.20,0.00,0.48
2021-07-16,2021-07-23,Pregnancy outcomes,Fetal growth restriction,4,0,0,0,4,0.01,0.00,0.00,0.01
2021-07-16,2021-07-23,Pregnancy outcomes,Spontaneous abortion,16,4,0,0,20,0.05,0.04,0.00,0.02
2021-07-16,2021-07-23,Pregnancy outcomes,Subtotal n (%),20,4,0,0,24,0.07,0.04,0.00,0.06
2021-07-16,2021-07-23,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,2,0.01,0.01,0.00,0.00
2021-07-16,2021-07-23,Respiratory system,Subtotal n (%),2,1,0,0,2,0.01,0.01,0.00,0.00
2021-07-16,2021-07-23,"Skin and mucous membrane, bone and joints system",Chilblains,6,0,0,0,6,0.02,0.00,0.00,0.01
2021-07-16,2021-07-23,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),9,3,1,0,13,0.03,0.03,0.04,0.03
2021-07-16,2021-07-23,"Skin and mucous membrane, bone and joints system",Subtotal n (%),15,3,1,0,19,0.05,0.03,0.04,0.04
2021-07-16,2021-07-23,All AESI categories,TOTAL,939,279,448,10,1675,3.18,2.67,16.27,3.91
2021-07-23,2021-07-30,Auto-immune diseases,Guillain-Barré Syndrome,20,8,25,0,53,0.06,0.07,0.91,0.12
2021-07-23,2021-07-30,Auto-immune diseases,Thrombocytopenia (low blood platelets),15,5,45,2,67,0.05,0.04,1.63,0.15
2021-07-23,2021-07-30,Auto-immune diseases,Subtotal n (%),35,13,70,2,120,0.11,0.11,2.53,0.26
2021-07-23,2021-07-30,Cardiovascular system,Cardiac arrest,8,8,5,0,21,0.03,0.07,0.18,0.05
2021-07-23,2021-07-30,Cardiovascular system,Cardiac failure,9,2,3,0,14,0.03,0.02,0.11,0.03
2021-07-23,2021-07-30,Cardiovascular system,Myocardial infarction (heart attack),32,13,8,1,54,0.10,0.11,0.29,0.12
2021-07-23,2021-07-30,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),145,71,12,2,230,0.46,0.62,0.43,0.51
2021-07-23,2021-07-30,Cardiovascular system,Subtotal n (%),194,94,28,3,319,0.62,0.82,1.01,0.70
2021-07-23,2021-07-30,Circulatory system,Cerebral venous (sinus) thrombosis,3,0,14,0,17,0.01,0.00,0.51,0.04
2021-07-23,2021-07-30,Circulatory system,Cerebral thrombosis ,2,1,2,0,5,0.01,0.01,0.07,0.01
2021-07-23,2021-07-30,Circulatory system,Cutaneous vasculitis,4,3,0,0,7,0.01,0.03,0.00,0.02
2021-07-23,2021-07-30,Circulatory system,Deep vein thrombosis,65,22,49,0,136,0.21,0.19,1.77,0.30
2021-07-23,2021-07-30,Circulatory system,Embolism,2,1,6,0,9,0.01,0.01,0.22,0.02
2021-07-23,2021-07-30,Circulatory system,Haemorrhage (bleeding),16,7,8,0,31,0.05,0.06,0.29,0.07
2021-07-23,2021-07-30,Circulatory system,Pulmonary embolism,88,32,91,1,212,0.28,0.28,3.30,0.47
2021-07-23,2021-07-30,Circulatory system,Thrombosis (blood clot),58,8,69,2,137,0.19,0.07,2.50,0.30
2021-07-23,2021-07-30,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),9,2,56,0,67,0.03,0.02,2.03,0.15
2021-07-23,2021-07-30,Circulatory system,Subtotal n (%),247,76,295,3,621,0.79,0.66,10.68,1.36
2021-07-23,2021-07-30,Hepato-gastrointestinal and renal system,Acute kidney injury,14,4,1,0,19,0.04,0.03,0.04,0.04
2021-07-23,2021-07-30,Hepato-gastrointestinal and renal system,Liver injury,6,2,2,0,10,0.02,0.02,0.07,0.02
2021-07-23,2021-07-30,Hepato-gastrointestinal and renal system,Subtotal n (%),20,6,3,0,29,0.06,0.05,0.11,0.06
2021-07-23,2021-07-30,Nerves and central nervous system,Bell's Palsy/facial paralysis,191,63,36,1,291,0.61,0.55,1.30,0.64
2021-07-23,2021-07-30,Nerves and central nervous system,Cerebrovascular accident (stroke),58,15,29,2,104,0.19,0.13,1.05,0.23
2021-07-23,2021-07-30,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),11,3,4,0,18,0.04,0.03,0.14,0.04
2021-07-23,2021-07-30,Nerves and central nervous system,Subtotal n (%),260,81,69,3,413,0.83,0.70,2.50,0.91
2021-07-23,2021-07-30,Other system,Anaphylaxis,113,24,0,0,137,0.36,0.21,0.00,0.30
2021-07-23,2021-07-30,Other system,COVID-19*,90,1,1,0,92,0.29,0.01,0.04,0.20
2021-07-23,2021-07-30,Other system,Subtotal n (%),203,25,1,0,229,0.65,0.22,0.04,0.50
2021-07-23,2021-07-30,Pregnancy outcomes,Fetal growth restriction,4,0,0,0,4,0.01,0.00,0.00,0.01
2021-07-23,2021-07-30,Pregnancy outcomes,Spontaneous abortion,16,4,0,0,20,0.05,0.03,0.00,0.04
2021-07-23,2021-07-30,Pregnancy outcomes,Subtotal n (%),20,4,0,0,24,0.06,0.03,0.00,0.05
2021-07-23,2021-07-30,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,2,0.01,0.01,0.00,0.00
2021-07-23,2021-07-30,Respiratory system,Subtotal n (%),2,1,0,0,2,0.01,0.01,0.00,0.00
2021-07-23,2021-07-30,"Skin and mucous membrane, bone and joints system",Chilblains,6,1,0,0,7,0.02,0.01,0.00,0.02
2021-07-23,2021-07-30,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),9,3,1,0,13,0.03,0.03,0.04,0.03
2021-07-23,2021-07-30,"Skin and mucous membrane, bone and joints system",Subtotal n (%),15,4,1,0,20,0.05,0.03,0.04,0.04
2021-07-23,2021-07-30,All AESI categories,TOTAL,996,304,467,11,1777,3.19,2.64,16.91,3.91
2021-07-30,2021-08-06,Auto-immune diseases,Guillain-Barré Syndrome,21,8,26,0,55,0.06,0.07,0.94,0.11
2021-07-30,2021-08-06,Auto-immune diseases,Thrombocytopenia (low blood platelets),17,7,40,2,66,0.05,0.06,1.45,0.14
2021-07-30,2021-08-06,Auto-immune diseases,Subtotal n (%),38,15,66,2,121,0.11,0.12,2.38,0.25
2021-07-30,2021-08-06,Cardiovascular system,Cardiac arrest,8,8,5,0,21,0.02,0.07,0.18,0.04
2021-07-30,2021-08-06,Cardiovascular system,Cardiac failure,9,2,3,1,15,0.03,0.02,0.11,0.03
2021-07-30,2021-08-06,Cardiovascular system,Myocardial infarction (heart attack),33,14,8,1,56,0.10,0.12,0.29,0.12
2021-07-30,2021-08-06,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),194,145,13,2,354,0.59,1.20,0.47,0.74
2021-07-30,2021-08-06,Cardiovascular system,Subtotal n (%),244,169,29,4,446,0.74,1.40,1.05,0.93
2021-07-30,2021-08-06,Circulatory system,Cerebral venous (sinus) thrombosis,2,1,12,0,15,0.01,0.01,0.43,0.03
2021-07-30,2021-08-06,Circulatory system,Cerebral thrombosis,2,1,2,0,5,0.01,0.01,0.07,0.01
2021-07-30,2021-08-06,Circulatory system,Cutaneous vasculitis,5,3,0,0,8,0.02,0.02,0.00,0.02
2021-07-30,2021-08-06,Circulatory system,Deep vein thrombosis,77,24,49,0,150,0.23,0.20,1.77,0.31
2021-07-30,2021-08-06,Circulatory system,Embolism,2,1,5,0,8,0.01,0.01,0.18,0.02
2021-07-30,2021-08-06,Circulatory system,Haemorrhage (bleeding),17,7,8,0,32,0.05,0.06,0.29,0.07
2021-07-30,2021-08-06,Circulatory system,Pulmonary embolism,95,35,90,1,221,0.29,0.29,3.25,0.46
2021-07-30,2021-08-06,Circulatory system,Thrombosis (blood clot),64,13,70,2,149,0.19,0.11,2.53,0.31
2021-07-30,2021-08-06,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),13,3,56,0,72,0.04,0.02,2.02,0.15
2021-07-30,2021-08-06,Circulatory system,Subtotal n (%),277,88,292,3,660,0.84,0.73,10.55,1.38
2021-07-30,2021-08-06,Hepato-gastrointestinal and renal system,Acute kidney injury,14,7,2,0,23,0.04,0.06,0.07,0.05
2021-07-30,2021-08-06,Hepato-gastrointestinal and renal system,Liver injury,7,2,3,0,12,0.02,0.02,0.11,0.03
2021-07-30,2021-08-06,Hepato-gastrointestinal and renal system,Subtotal n (%),21,9,5,0,35,0.06,0.07,0.18,0.07
2021-07-30,2021-08-06,Nerves and central nervous system,Bell's Palsy/facial paralysis,206,67,37,1,311,0.62,0.56,1.34,0.65
2021-07-30,2021-08-06,Nerves and central nervous system,Cerebrovascular accident (stroke),62,20,29,2,113,0.19,0.17,1.05,0.24
2021-07-30,2021-08-06,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),11,3,4,0,18,0.03,0.02,0.14,0.04
2021-07-30,2021-08-06,Nerves and central nervous system,Subtotal n (%),279,90,70,3,442,0.84,0.75,2.53,0.92
2021-07-30,2021-08-06,Other system,Anaphylaxis,123,27,0,0,150,0.37,0.22,0.00,0.31
2021-07-30,2021-08-06,Other system,COVID-19*,91,2,1,1,95,0.28,0.02,0.04,0.20
2021-07-30,2021-08-06,Other system,Subtotal n (%),214,29,1,1,245,0.65,0.24,0.04,0.51
2021-07-30,2021-08-06,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.02,0.00,0.00,0.01
2021-07-30,2021-08-06,Pregnancy outcomes,Spontaneous abortion,17,5,0,0,22,0.05,0.04,0.00,0.05
2021-07-30,2021-08-06,Pregnancy outcomes,Subtotal n (%),22,5,0,0,27,0.07,0.04,0.00,0.06
2021-07-30,2021-08-06,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-07-30,2021-08-06,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-07-30,2021-08-06,"Skin and mucous membrane, bone and joints system",Chilblains,6,1,0,0,7,0.02,0.01,0.00,0.01
2021-07-30,2021-08-06,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),9,6,1,0,16,0.03,0.05,0.04,0.03
2021-07-30,2021-08-06,"Skin and mucous membrane, bone and joints system",Subtotal n (%),15,7,1,0,23,0.05,0.06,0.04,0.05
2021-07-30,2021-08-06,All AESI categories,TOTAL,1112,413,464,13,2002,3.36,3.43,16.77,4.18
2021-08-06,2021-08-13,Auto-immune diseases,Guillain-Barré Syndrome,22,9,27,0,58,0.06,0.07,0.97,0.12
2021-08-06,2021-08-13,Auto-immune diseases,Thrombocytopenia (low blood platelets),17,7,40,3,67,0.05,0.06,1.44,0.14
2021-08-06,2021-08-13,Auto-immune diseases,Subtotal n (%),39,16,67,3,125,0.11,0.13,2.42,0.25
2021-08-06,2021-08-13,Cardiovascular system,Cardiac arrest,8,8,5,0,21,0.02,0.06,0.18,0.04
2021-08-06,2021-08-13,Cardiovascular system,Cardiac failure,9,3,3,1,16,0.03,0.02,0.11,0.03
2021-08-06,2021-08-13,Cardiovascular system,Myocardial infarction (heart attack),33,14,8,1,56,0.10,0.11,0.29,0.11
2021-08-06,2021-08-13,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),223,184,14,2,423,0.65,1.49,0.50,0.85
2021-08-06,2021-08-13,Cardiovascular system,Subtotal n (%),273,209,30,4,516,0.79,1.69,1.08,1.04
2021-08-06,2021-08-13,Circulatory system,Cerebral venous (sinus) thrombosis,2,1,11,0,14,0.01,0.01,0.40,0.03
2021-08-06,2021-08-13,Circulatory system,Cerebral thrombosis,2,1,2,0,5,0.01,0.01,0.07,0.01
2021-08-06,2021-08-13,Circulatory system,Cutaneous vasculitis,7,3,0,0,10,0.02,0.02,0.00,0.02
2021-08-06,2021-08-13,Circulatory system,Deep vein thrombosis,81,26,50,0,157,0.24,0.21,1.80,0.32
2021-08-06,2021-08-13,Circulatory system,Embolism,2,1,5,0,8,0.01,0.01,0.18,0.02
2021-08-06,2021-08-13,Circulatory system,Haemorrhage (bleeding),18,7,8,0,33,0.05,0.06,0.29,0.07
2021-08-06,2021-08-13,Circulatory system,Pulmonary embolism,101,35,91,1,228,0.29,0.28,3.28,0.46
2021-08-06,2021-08-13,Circulatory system,Thrombosis (blood clot),68,14,70,2,154,0.20,0.11,2.52,0.31
2021-08-06,2021-08-13,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),13,3,56,0,72,0.04,0.02,2.02,0.15
2021-08-06,2021-08-13,Circulatory system,Subtotal n (%),294,91,293,3,681,0.85,0.74,10.57,1.37
2021-08-06,2021-08-13,Hepato-gastrointestinal and renal system,Acute kidney injury,14,7,2,0,23,0.04,0.06,0.07,0.05
2021-08-06,2021-08-13,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),2,0,0,0,2,0.01,0.00,0.00,0.00
2021-08-06,2021-08-13,Hepato-gastrointestinal and renal system,Liver injury,8,2,3,0,13,0.02,0.02,0.11,0.03
2021-08-06,2021-08-13,Hepato-gastrointestinal and renal system,Subtotal n (%),24,9,5,0,38,0.07,0.07,0.18,0.08
2021-08-06,2021-08-13,Nerves and central nervous system,Bell's Palsy/facial paralysis,218,76,38,1,333,0.63,0.62,1.37,0.67
2021-08-06,2021-08-13,Nerves and central nervous system,Cerebrovascular accident (stroke),65,20,30,2,117,0.19,0.16,1.08,0.24
2021-08-06,2021-08-13,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),11,3,4,0,18,0.03,0.02,0.14,0.04
2021-08-06,2021-08-13,Nerves and central nervous system,Subtotal n (%),294,99,72,3,468,0.85,0.80,2.60,0.94
2021-08-06,2021-08-13,Other system,Anaphylaxis,126,29,0,0,155,0.37,0.23,0.00,0.31
2021-08-06,2021-08-13,Other system,COVID-19*,92,2,1,1,96,0.27,0.02,0.04,0.19
2021-08-06,2021-08-13,Other system,Subtotal n (%),218,31,1,1,251,0.63,0.25,0.04,0.51
2021-08-06,2021-08-13,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-08-06,2021-08-13,Pregnancy outcomes,Spontaneous abortion,21,5,0,0,26,0.06,0.04,0.00,0.05
2021-08-06,2021-08-13,Pregnancy outcomes,Subtotal n (%),26,5,0,0,31,0.08,0.04,0.00,0.06
2021-08-06,2021-08-13,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-08-06,2021-08-13,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-08-06,2021-08-13,"Skin and mucous membrane, bone and joints system",Chilblains,6,2,0,0,8,0.02,0.02,0.00,0.02
2021-08-06,2021-08-13,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),10,6,1,0,17,0.03,0.05,0.04,0.03
2021-08-06,2021-08-13,"Skin and mucous membrane, bone and joints system",Subtotal n (%),16,8,1,0,25,0.05,0.06,0.04,0.05
2021-08-06,2021-08-13,All AESI categories,TOTAL,1186,469,469,14,2138,3.44,3.80,16.92,4.31
2021-08-13,2021-08-20,Auto-immune diseases,Guillain-Barré Syndrome,24,11,29,0,64,0.07,0.09,1.04,0.13
2021-08-13,2021-08-20,Auto-immune diseases,Thrombocytopenia (low blood platelets),17,8,40,3,68,0.05,0.06,1.44,0.13
2021-08-13,2021-08-20,Auto-immune diseases,Subtotal n (%),41,19,69,3,132,0.12,0.15,2.48,0.26
2021-08-13,2021-08-20,Cardiovascular system,Cardiac arrest,9,8,5,0,22,0.03,0.06,0.18,0.04
2021-08-13,2021-08-20,Cardiovascular system,Cardiac failure,10,3,3,1,17,0.03,0.02,0.11,0.03
2021-08-13,2021-08-20,Cardiovascular system,Myocardial infarction (heart attack),38,14,8,2,62,0.11,0.11,0.29,0.12
2021-08-13,2021-08-20,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),255,212,16,2,485,0.72,1.69,0.58,0.96
2021-08-13,2021-08-20,Cardiovascular system,Subtotal n (%),312,237,32,5,586,0.88,1.89,1.15,1.16
2021-08-13,2021-08-20,Circulatory system,Cerebral venous (sinus) thrombosis,2,1,11,0,14,0.01,0.01,0.40,0.03
2021-08-13,2021-08-20,Circulatory system,Cerebral thrombosis,2,1,2,0,5,0.01,0.01,0.07,0.01
2021-08-13,2021-08-20,Circulatory system,Cutaneous vasculitis,7,4,0,0,11,0.02,0.03,0.00,0.02
2021-08-13,2021-08-20,Circulatory system,Deep vein thrombosis,87,27,51,0,165,0.25,0.21,1.84,0.33
2021-08-13,2021-08-20,Circulatory system,Embolism,2,1,5,0,8,0.01,0.01,0.18,0.02
2021-08-13,2021-08-20,Circulatory system,Haemorrhage (bleeding),19,8,7,0,34,0.05,0.06,0.25,0.07
2021-08-13,2021-08-20,Circulatory system,Pulmonary embolism,108,38,97,1,244,0.31,0.30,3.49,0.48
2021-08-13,2021-08-20,Circulatory system,Thrombosis (blood clot),72,15,74,1,162,0.20,0.12,2.67,0.32
2021-08-13,2021-08-20,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),15,3,60,0,78,0.04,0.02,2.16,0.15
2021-08-13,2021-08-20,Circulatory system,Subtotal n (%),314,98,307,2,721,0.89,0.78,11.06,1.42
2021-08-13,2021-08-20,Hepato-gastrointestinal and renal system,Acute kidney injury,15,8,3,0,26,0.04,0.06,0.11,0.05
2021-08-13,2021-08-20,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),3,0,1,0,4,0.01,0.00,0.04,0.01
2021-08-13,2021-08-20,Hepato-gastrointestinal and renal system,Liver injury,10,2,3,0,15,0.03,0.02,0.11,0.03
2021-08-13,2021-08-20,Hepato-gastrointestinal and renal system,Subtotal n (%),28,10,7,0,45,0.08,0.08,0.25,0.09
2021-08-13,2021-08-20,Nerves and central nervous system,Bell's Palsy/facial paralysis,235,80,39,1,355,0.67,0.64,1.40,0.70
2021-08-13,2021-08-20,Nerves and central nervous system,Cerebrovascular accident (stroke),67,21,32,3,123,0.19,0.17,1.15,0.24
2021-08-13,2021-08-20,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),11,3,3,0,17,0.03,0.02,0.11,0.03
2021-08-13,2021-08-20,Nerves and central nervous system,Subtotal n (%),313,104,74,4,495,0.89,0.83,2.67,0.98
2021-08-13,2021-08-20,Other system,Anaphylaxis*,128,30,0,0,158,0.36,0.24,0.00,0.31
2021-08-13,2021-08-20,Other system,COVID-19*,92,4,2,2,100,0.26,0.03,0.07,0.20
2021-08-13,2021-08-20,Other system,Subtotal n (%),220,34,2,2,258,0.62,0.27,0.07,0.51
2021-08-13,2021-08-20,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-08-13,2021-08-20,Pregnancy outcomes,Spontaneous abortion,23,6,1,0,30,0.07,0.05,0.04,0.06
2021-08-13,2021-08-20,Pregnancy outcomes,Subtotal n (%),28,6,1,0,35,0.08,0.05,0.04,0.07
2021-08-13,2021-08-20,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-08-13,2021-08-20,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-08-13,2021-08-20,"Skin and mucous membrane, bone and joints system",Chilblains,7,3,1,0,11,0.02,0.02,0.04,0.02
2021-08-13,2021-08-20,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),10,6,1,0,17,0.03,0.05,0.04,0.03
2021-08-13,2021-08-20,"Skin and mucous membrane, bone and joints system",Subtotal n (%),17,9,2,0,28,0.05,0.07,0.07,0.06
2021-08-13,2021-08-20,All AESI categories,TOTAL,1275,518,494,16,2303,3.61,4.12,17.79,4.55
2021-08-20,2021-08-27,Auto-immune diseases,Guillain-Barré Syndrome,25,12,29,0,66,0.07,0.09,1.04,0.13
2021-08-20,2021-08-27,Auto-immune diseases,Thrombocytopenia (low blood platelets),19,8,38,3,68,0.05,0.06,1.37,0.13
2021-08-20,2021-08-27,Auto-immune diseases,Subtotal n (%),44,20,67,3,134,0.12,0.16,2.41,0.26
2021-08-20,2021-08-27,Cardiovascular system,Cardiac arrest,9,8,5,0,22,0.03,0.06,0.18,0.04
2021-08-20,2021-08-27,Cardiovascular system,Cardiac failure,13,5,3,1,22,0.04,0.04,0.11,0.04
2021-08-20,2021-08-27,Cardiovascular system,Myocardial infarction (heart attack),42,16,8,2,68,0.12,0.12,0.29,0.13
2021-08-20,2021-08-27,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),303,236,16,2,557,0.84,1.84,0.58,1.08
2021-08-20,2021-08-27,Cardiovascular system,Subtotal n (%),367,265,32,5,669,1.02,2.07,1.15,1.30
2021-08-20,2021-08-27,Circulatory system,Cerebral venous (sinus) thrombosis,2,1,11,0,14,0.01,0.01,0.40,0.03
2021-08-20,2021-08-27,Circulatory system,Cerebral thrombosis,2,1,1,0,4,0.01,0.01,0.04,0.01
2021-08-20,2021-08-27,Circulatory system,Cutaneous vasculitis,8,4,0,0,12,0.02,0.03,0.00,0.02
2021-08-20,2021-08-27,Circulatory system,Deep vein thrombosis,91,28,52,0,171,0.25,0.22,1.87,0.33
2021-08-20,2021-08-27,Circulatory system,Embolism,2,1,5,0,8,0.01,0.01,0.18,0.02
2021-08-20,2021-08-27,Circulatory system,Haemorrhage (bleeding),21,8,7,0,36,0.06,0.06,0.25,0.07
2021-08-20,2021-08-27,Circulatory system,Pulmonary embolism,115,40,100,1,256,0.32,0.31,3.60,0.50
2021-08-20,2021-08-27,Circulatory system,Thrombosis (blood clot),75,16,74,1,166,0.21,0.12,2.66,0.32
2021-08-20,2021-08-27,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),15,3,60,0,78,0.04,0.02,2.16,0.15
2021-08-20,2021-08-27,Circulatory system,Subtotal n (%),331,102,310,2,745,0.92,0.80,11.15,1.44
2021-08-20,2021-08-27,Hepato-gastrointestinal and renal system,Acute kidney injury,16,9,3,0,28,0.04,0.07,0.11,0.05
2021-08-20,2021-08-27,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),3,0,1,0,4,0.01,0.00,0.04,0.01
2021-08-20,2021-08-27,Hepato-gastrointestinal and renal system,Liver injury,11,3,3,0,17,0.03,0.02,0.11,0.03
2021-08-20,2021-08-27,Hepato-gastrointestinal and renal system,Subtotal n (%),30,12,7,0,49,0.08,0.09,0.25,0.09
2021-08-20,2021-08-27,Nerves and central nervous system,Bell's Palsy/facial paralysis,265,86,39,1,391,0.74,0.67,1.40,0.76
2021-08-20,2021-08-27,Nerves and central nervous system,Cerebrovascular accident (stroke),69,22,33,4,128,0.19,0.17,1.19,0.25
2021-08-20,2021-08-27,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),11,3,3,0,17,0.03,0.02,0.11,0.03
2021-08-20,2021-08-27,Nerves and central nervous system,Subtotal n (%),345,111,75,5,536,0.96,0.87,2.70,1.04
2021-08-20,2021-08-27,Other system,Anaphylaxis*,130,30,0,0,160,0.36,0.23,0.00,0.31
2021-08-20,2021-08-27,Other system,COVID-19*,96,5,2,2,105,0.27,0.04,0.07,0.20
2021-08-20,2021-08-27,Other system,Subtotal n (%),226,35,2,2,265,0.63,0.27,0.07,0.51
2021-08-20,2021-08-27,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-08-20,2021-08-27,Pregnancy outcomes,Spontaneous abortion,22,6,1,0,29,0.06,0.05,0.04,0.06
2021-08-20,2021-08-27,Pregnancy outcomes,Subtotal n (%),27,6,1,0,34,0.08,0.05,0.04,0.07
2021-08-20,2021-08-27,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-08-20,2021-08-27,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-08-20,2021-08-27,"Skin and mucous membrane, bone and joints system",Chilblains,7,3,1,0,11,0.02,0.02,0.04,0.02
2021-08-20,2021-08-27,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),10,6,1,0,17,0.03,0.05,0.04,0.03
2021-08-20,2021-08-27,"Skin and mucous membrane, bone and joints system",Subtotal n (%),17,9,2,0,28,0.05,0.07,0.07,0.05
2021-08-20,2021-08-27,All AESI categories,TOTAL,1389,561,496,17,2463,3.86,4.38,17.84,4.77
2021-08-27,2021-09-03,Auto-immune diseases,Guillain-Barré Syndrome,28,15,30,0,73,0.08,0.12,1.08,0.14
2021-08-27,2021-09-03,Auto-immune diseases,Thrombocytopenia (low blood platelets),19,8,38,3,68,0.05,0.06,1.37,0.13
2021-08-27,2021-09-03,Auto-immune diseases,Subtotal n (%),47,23,68,3,141,0.13,0.18,2.44,0.27
2021-08-27,2021-09-03,Cardiovascular system,Cardiac arrest,10,8,5,0,23,0.03,0.06,0.18,0.04
2021-08-27,2021-09-03,Cardiovascular system,Cardiac failure,17,5,3,1,26,0.05,0.04,0.11,0.05
2021-08-27,2021-09-03,Cardiovascular system,Myocardial infarction (heart attack),44,16,8,3,71,0.12,0.12,0.29,0.14
2021-08-27,2021-09-03,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),347,265,17,2,631,0.95,2.04,0.61,1.21
2021-08-27,2021-09-03,Cardiovascular system,Subtotal n (%),418,294,33,6,751,1.14,2.26,1.19,1.43
2021-08-27,2021-09-03,Circulatory system,Cerebral venous (sinus) thrombosis,2,1,11,0,14,0.01,0.01,0.40,0.03
2021-08-27,2021-09-03,Circulatory system,Cerebral thrombosis ,3,1,2,0,6,0.01,0.01,0.07,0.01
2021-08-27,2021-09-03,Circulatory system,Cutaneous vasculitis,11,5,0,0,16,0.03,0.04,0.00,0.03
2021-08-27,2021-09-03,Circulatory system,Deep vein thrombosis,104,30,52,0,186,0.28,0.23,1.87,0.35
2021-08-27,2021-09-03,Circulatory system,Embolism,3,1,5,0,9,0.01,0.01,0.18,0.02
2021-08-27,2021-09-03,Circulatory system,Haemorrhage (bleeding),22,8,8,1,39,0.06,0.06,0.29,0.07
2021-08-27,2021-09-03,Circulatory system,Pulmonary embolism,123,43,101,1,268,0.34,0.33,3.63,0.51
2021-08-27,2021-09-03,Circulatory system,Thrombosis (blood clot),76,19,75,1,171,0.21,0.15,2.70,0.33
2021-08-27,2021-09-03,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),16,4,61,0,81,0.04,0.03,2.19,0.15
2021-08-27,2021-09-03,Circulatory system,Subtotal n (%),360,112,315,3,790,0.98,0.86,11.32,1.51
2021-08-27,2021-09-03,Hepato-gastrointestinal and renal system,Acute kidney injury,16,11,3,0,30,0.04,0.08,0.11,0.06
2021-08-27,2021-09-03,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),3,1,1,0,5,0.01,0.01,0.04,0.01
2021-08-27,2021-09-03,Hepato-gastrointestinal and renal system,Liver injury,11,6,3,0,20,0.03,0.05,0.11,0.04
2021-08-27,2021-09-03,Hepato-gastrointestinal and renal system,Subtotal n (%),30,18,7,0,55,0.08,0.14,0.25,0.10
2021-08-27,2021-09-03,Nerves and central nervous system,Bell's Palsy/facial paralysis*,291,95,41,1,428,0.79,0.73,1.47,0.82
2021-08-27,2021-09-03,Nerves and central nervous system,Cerebrovascular accident (stroke),70,23,34,4,131,0.19,0.18,1.22,0.25
2021-08-27,2021-09-03,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),12,4,4,0,20,0.03,0.03,0.14,0.04
2021-08-27,2021-09-03,Nerves and central nervous system,Subtotal n (%),373,122,79,5,579,1.02,0.94,2.84,1.10
2021-08-27,2021-09-03,Other system,Anaphylaxis*,131,30,0,0,161,0.36,0.23,0.00,0.31
2021-08-27,2021-09-03,Other system,COVID-19*,99,5,2,3,109,0.27,0.04,0.07,0.21
2021-08-27,2021-09-03,Other system,Multisystem inflammatory syndrome,1,1,0,0,2,0.00,0.01,0.00,0.00
2021-08-27,2021-09-03,Other system,Subtotal n (%),231,36,2,3,272,0.63,0.28,0.07,0.52
2021-08-27,2021-09-03,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-08-27,2021-09-03,Pregnancy outcomes,Spontaneous abortion,22,6,1,0,29,0.06,0.05,0.04,0.06
2021-08-27,2021-09-03,Pregnancy outcomes,Subtotal n (%),27,6,1,0,34,0.07,0.05,0.04,0.06
2021-08-27,2021-09-03,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-08-27,2021-09-03,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-08-27,2021-09-03,"Skin and mucous membrane, bone and joints system",Chilblains,7,3,1,0,11,0.02,0.02,0.04,0.02
2021-08-27,2021-09-03,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),10,9,1,0,20,0.03,0.07,0.04,0.04
2021-08-27,2021-09-03,"Skin and mucous membrane, bone and joints system",Subtotal n (%),17,12,2,0,31,0.05,0.09,0.07,0.06
2021-08-27,2021-09-03,All AESI categories,TOTAL,1505,624,507,20,2656,4.11,4.80,18.22,5.06
2021-09-03,2021-09-10,Auto-immune diseases,Guillain-Barré Syndrome,30,15,30,0,75,0.08,0.11,1.08,0.14
2021-09-03,2021-09-10,Auto-immune diseases,Thrombocytopenia (low blood platelets),20,8,37,3,68,0.05,0.06,1.33,0.13
2021-09-03,2021-09-10,Auto-immune diseases,Subtotal n (%),50,23,67,3,143,0.13,0.17,2.41,0.27
2021-09-03,2021-09-10,Cardiovascular system,Cardiac arrest,10,9,5,0,24,0.03,0.07,0.18,0.05
2021-09-03,2021-09-10,Cardiovascular system,Cardiac failure,17,5,3,1,26,0.05,0.04,0.11,0.05
2021-09-03,2021-09-10,Cardiovascular system,Myocardial infarction (heart attack),45,16,8,3,72,0.12,0.12,0.29,0.14
2021-09-03,2021-09-10,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),384,276,16,2,678,1.03,2.09,0.57,1.27
2021-09-03,2021-09-10,Cardiovascular system,Subtotal n (%),456,306,32,6,800,1.23,2.32,1.15,1.50
2021-09-03,2021-09-10,Circulatory system,Cerebral venous (sinus) thrombosis,2,1,11,0,14,0.01,0.01,0.40,0.03
2021-09-03,2021-09-10,Circulatory system,Cerebral thrombosis ,3,1,2,0,6,0.01,0.01,0.07,0.01
2021-09-03,2021-09-10,Circulatory system,Cutaneous vasculitis,12,5,3,0,20,0.03,0.04,0.11,0.04
2021-09-03,2021-09-10,Circulatory system,Deep vein thrombosis,108,32,53,0,193,0.29,0.24,1.90,0.36
2021-09-03,2021-09-10,Circulatory system,Embolism,3,1,6,0,10,0.01,0.01,0.22,0.02
2021-09-03,2021-09-10,Circulatory system,Haemorrhage (bleeding),21,8,8,1,38,0.06,0.06,0.29,0.07
2021-09-03,2021-09-10,Circulatory system,Pulmonary embolism,128,47,106,0,281,0.34,0.36,3.81,0.53
2021-09-03,2021-09-10,Circulatory system,Thrombosis (blood clot),78,20,75,1,174,0.21,0.15,2.69,0.33
2021-09-03,2021-09-10,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),16,4,61,0,81,0.04,0.03,2.19,0.15
2021-09-03,2021-09-10,Circulatory system,Subtotal n (%),371,119,325,2,817,1.00,0.90,11.67,1.54
2021-09-03,2021-09-10,Hepato-gastrointestinal and renal system,Acute kidney injury,16,11,3,0,30,0.04,0.08,0.11,0.06
2021-09-03,2021-09-10,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),2,1,2,0,5,0.01,0.01,0.07,0.01
2021-09-03,2021-09-10,Hepato-gastrointestinal and renal system,Liver injury,11,6,3,0,20,0.03,0.05,0.11,0.04
2021-09-03,2021-09-10,Hepato-gastrointestinal and renal system,Subtotal n (%),29,18,8,0,55,0.08,0.14,0.29,0.10
2021-09-03,2021-09-10,Nerves and central nervous system,Bell's Palsy/facial paralysis*,310,100,43,1,454,0.83,0.76,1.54,0.85
2021-09-03,2021-09-10,Nerves and central nervous system,Cerebrovascular accident (stroke),73,25,34,4,136,0.20,0.19,1.22,0.26
2021-09-03,2021-09-10,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),13,4,4,0,21,0.03,0.03,0.14,0.04
2021-09-03,2021-09-10,Nerves and central nervous system,Subtotal n (%),396,129,81,5,611,1.07,0.98,2.91,1.15
2021-09-03,2021-09-10,Other system,Anaphylaxis*,132,30,0,0,162,0.36,0.23,0.00,0.30
2021-09-03,2021-09-10,Other system,COVID-19*,102,5,2,4,113,0.27,0.04,0.07,0.21
2021-09-03,2021-09-10,Other system,Multisystem inflammatory syndrome,1,1,0,0,2,0.00,0.01,0.00,0.00
2021-09-03,2021-09-10,Other system,Subtotal n (%),235,36,2,4,277,0.63,0.27,0.07,0.52
2021-09-03,2021-09-10,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-09-03,2021-09-10,Pregnancy outcomes,Spontaneous abortion,23,6,1,0,30,0.06,0.05,0.04,0.06
2021-09-03,2021-09-10,Pregnancy outcomes,Subtotal n (%),28,6,1,0,35,0.08,0.05,0.04,0.07
2021-09-03,2021-09-10,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-09-03,2021-09-10,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-09-03,2021-09-10,"Skin and mucous membrane, bone and joints system",Chilblains,7,3,1,0,11,0.02,0.02,0.04,0.02
2021-09-03,2021-09-10,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),11,9,1,0,21,0.03,0.07,0.04,0.04
2021-09-03,2021-09-10,"Skin and mucous membrane, bone and joints system",Subtotal n (%),18,12,2,0,32,0.05,0.09,0.07,0.06
2021-09-03,2021-09-10,All AESI categories,TOTAL,1585,650,518,20,2773,4.27,4.93,18.60,5.21
2021-09-10,2021-09-17,Auto-immune diseases,Guillain-Barré Syndrome,31,15,30,0,76,0.08,0.11,1.08,0.14
2021-09-10,2021-09-17,Auto-immune diseases,Thrombocytopenia (low blood platelets),20,7,41,3,71,0.05,0.05,1.47,0.13
2021-09-10,2021-09-17,Auto-immune diseases,Subtotal n (%),51,22,71,3,147,0.14,0.16,2.55,0.27
2021-09-10,2021-09-17,Cardiovascular system,Cardiac arrest,10,9,5,0,24,0.03,0.07,0.18,0.04
2021-09-10,2021-09-17,Cardiovascular system,Cardiac failure,18,5,3,1,27,0.05,0.04,0.11,0.05
2021-09-10,2021-09-17,Cardiovascular system,Myocardial infarction (heart attack),46,15,6,3,70,0.12,0.11,0.22,0.13
2021-09-10,2021-09-17,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),408,290,18,2,718,1.08,2.17,0.65,1.34
2021-09-10,2021-09-17,Cardiovascular system,Subtotal n (%),482,319,32,6,839,1.28,2.39,1.15,1.56
2021-09-10,2021-09-17,Circulatory system,Cerebral venous (sinus) thrombosis,2,1,12,0,15,0.01,0.01,0.43,0.03
2021-09-10,2021-09-17,Circulatory system,Cerebral thrombosis ,3,1,2,0,6,0.01,0.01,0.07,0.01
2021-09-10,2021-09-17,Circulatory system,Cutaneous vasculitis,12,5,3,0,20,0.03,0.04,0.11,0.04
2021-09-10,2021-09-17,Circulatory system,Deep vein thrombosis,110,33,53,0,196,0.29,0.25,1.90,0.36
2021-09-10,2021-09-17,Circulatory system,Embolism,3,1,6,0,10,0.01,0.01,0.22,0.02
2021-09-10,2021-09-17,Circulatory system,Haemorrhage (bleeding),24,8,8,1,41,0.06,0.06,0.29,0.08
2021-09-10,2021-09-17,Circulatory system,Pulmonary embolism,134,49,107,0,290,0.36,0.37,3.84,0.54
2021-09-10,2021-09-17,Circulatory system,Thrombosis (blood clot),78,20,79,1,178,0.21,0.15,2.84,0.33
2021-09-10,2021-09-17,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),16,4,61,0,81,0.04,0.03,2.19,0.15
2021-09-10,2021-09-17,Circulatory system,Subtotal n (%),382,122,331,2,837,1.02,0.91,11.88,1.56
2021-09-10,2021-09-17,Hepato-gastrointestinal and renal system,Acute kidney injury,16,11,3,0,30,0.04,0.08,0.11,0.06
2021-09-10,2021-09-17,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),2,1,2,0,5,0.01,0.01,0.07,0.01
2021-09-10,2021-09-17,Hepato-gastrointestinal and renal system,Liver injury,11,6,3,0,20,0.03,0.04,0.11,0.04
2021-09-10,2021-09-17,Hepato-gastrointestinal and renal system,Subtotal n (%),29,18,8,0,55,0.08,0.13,0.29,0.10
2021-09-10,2021-09-17,Nerves and central nervous system,Bell's Palsy/facial paralysis*,325,105,43,1,474,0.86,0.79,1.54,0.88
2021-09-10,2021-09-17,Nerves and central nervous system,Cerebrovascular accident (stroke),75,27,35,3,140,0.20,0.20,1.26,0.26
2021-09-10,2021-09-17,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),14,4,4,0,22,0.04,0.03,0.14,0.04
2021-09-10,2021-09-17,Nerves and central nervous system,Subtotal n (%),414,136,82,4,636,1.10,1.02,2.94,1.18
2021-09-10,2021-09-17,Other system,Anaphylaxis*,142,30,0,0,172,0.38,0.22,0.00,0.32
2021-09-10,2021-09-17,Other system,COVID-19*,108,5,2,4,119,0.29,0.04,0.07,0.22
2021-09-10,2021-09-17,Other system,Multisystem inflammatory syndrome,1,1,0,0,2,0.00,0.01,0.00,0.00
2021-09-10,2021-09-17,Other system,Subtotal n (%),251,36,2,4,293,0.67,0.27,0.07,0.54
2021-09-10,2021-09-17,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-09-10,2021-09-17,Pregnancy outcomes,Spontaneous abortion,24,6,1,0,31,0.06,0.04,0.04,0.06
2021-09-10,2021-09-17,Pregnancy outcomes,Subtotal n (%),29,6,1,0,36,0.08,0.04,0.04,0.07
2021-09-10,2021-09-17,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-09-10,2021-09-17,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-09-10,2021-09-17,"Skin and mucous membrane, bone and joints system",Chilblains,7,3,1,0,11,0.02,0.02,0.04,0.02
2021-09-10,2021-09-17,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),12,9,1,0,22,0.03,0.07,0.04,0.04
2021-09-10,2021-09-17,"Skin and mucous membrane, bone and joints system",Subtotal n (%),19,12,2,0,33,0.05,0.09,0.07,0.06
2021-09-10,2021-09-17,All AESI categories,TOTAL,1659,672,529,19,2879,4.41,5.04,18.99,5.35
2021-09-17,2021-09-24,Auto-immune diseases,Guillain-Barré Syndrome,33,16,30,0,79,0.09,0.12,1.08,0.15
2021-09-17,2021-09-24,Auto-immune diseases,Thrombocytopenia (low blood platelets),19,7,37,3,66,0.05,0.05,1.33,0.12
2021-09-17,2021-09-24,Auto-immune diseases,Subtotal n (%),52,23,67,3,145,0.14,0.17,2.40,0.27
2021-09-17,2021-09-24,Cardiovascular system,Cardiac arrest,10,9,5,0,24,0.03,0.07,0.18,0.04
2021-09-17,2021-09-24,Cardiovascular system,Cardiac failure,19,5,3,1,28,0.05,0.04,0.11,0.05
2021-09-17,2021-09-24,Cardiovascular system,Myocardial infarction (heart attack),46,16,6,3,71,0.12,0.12,0.22,0.13
2021-09-17,2021-09-24,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),445,306,19,4,774,1.17,2.27,0.68,1.42
2021-09-17,2021-09-24,Cardiovascular system,Subtotal n (%),520,336,33,8,897,1.37,2.49,1.18,1.65
2021-09-17,2021-09-24,Circulatory system,Cerebral venous (sinus) thrombosis,2,1,11,0,14,0.01,0.01,0.39,0.03
2021-09-17,2021-09-24,Circulatory system,Cerebral thrombosis ,3,1,2,0,6,0.01,0.01,0.07,0.01
2021-09-17,2021-09-24,Circulatory system,Cutaneous vasculitis,12,5,4,0,21,0.03,0.04,0.14,0.04
2021-09-17,2021-09-24,Circulatory system,Deep vein thrombosis,114,34,53,0,201,0.30,0.25,1.90,0.37
2021-09-17,2021-09-24,Circulatory system,Embolism,3,1,7,0,11,0.01,0.01,0.25,0.02
2021-09-17,2021-09-24,Circulatory system,Haemorrhage (bleeding),24,9,9,1,43,0.06,0.07,0.32,0.08
2021-09-17,2021-09-24,Circulatory system,Pulmonary embolism,137,51,108,0,296,0.36,0.38,3.88,0.54
2021-09-17,2021-09-24,Circulatory system,Thrombosis (blood clot),83,23,78,1,185,0.22,0.17,2.80,0.34
2021-09-17,2021-09-24,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),16,4,61,0,81,0.04,0.03,2.19,0.15
2021-09-17,2021-09-24,Circulatory system,Subtotal n (%),394,129,333,2,858,1.04,0.96,11.95,1.58
2021-09-17,2021-09-24,Hepato-gastrointestinal and renal system,Acute kidney injury,16,11,3,0,30,0.04,0.08,0.11,0.06
2021-09-17,2021-09-24,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),2,1,2,0,5,0.01,0.01,0.07,0.01
2021-09-17,2021-09-24,Hepato-gastrointestinal and renal system,Liver injury,12,6,3,0,21,0.03,0.04,0.11,0.04
2021-09-17,2021-09-24,Hepato-gastrointestinal and renal system,Subtotal n (%),30,18,8,0,56,0.08,0.13,0.29,0.10
2021-09-17,2021-09-24,Nerves and central nervous system,Bell's Palsy/facial paralysis*,340,110,43,1,494,0.89,0.82,1.54,0.91
2021-09-17,2021-09-24,Nerves and central nervous system,Cerebrovascular accident (stroke),76,29,34,3,142,0.20,0.22,1.22,0.26
2021-09-17,2021-09-24,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),17,5,4,0,26,0.04,0.04,0.14,0.05
2021-09-17,2021-09-24,Nerves and central nervous system,Subtotal n (%),433,144,81,4,662,1.14,1.07,2.91,1.22
2021-09-17,2021-09-24,Other system,Anaphylaxis*,157,40,4,0,201,0.41,0.30,0.14,0.37
2021-09-17,2021-09-24,Other system,COVID-19*,108,5,2,4,119,0.28,0.04,0.07,0.22
2021-09-17,2021-09-24,Other system,Multisystem inflammatory syndrome,1,1,0,0,2,0.00,0.01,0.00,0.00
2021-09-17,2021-09-24,Other system,Subtotal n (%),266,46,6,4,322,0.70,0.34,0.22,0.59
2021-09-17,2021-09-24,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-09-17,2021-09-24,Pregnancy outcomes,Spontaneous abortion,27,6,1,0,34,0.07,0.04,0.04,0.06
2021-09-17,2021-09-24,Pregnancy outcomes,Subtotal n (%),32,6,1,0,39,0.08,0.04,0.04,0.07
2021-09-17,2021-09-24,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-09-17,2021-09-24,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-09-17,2021-09-24,"Skin and mucous membrane, bone and joints system",Chilblains,9,3,1,0,13,0.02,0.02,0.04,0.02
2021-09-17,2021-09-24,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),13,9,1,0,23,0.03,0.07,0.04,0.04
2021-09-17,2021-09-24,"Skin and mucous membrane, bone and joints system",Subtotal n (%),22,12,2,0,36,0.06,0.09,0.07,0.07
2021-09-17,2021-09-24,All AESI categories,TOTAL,1751,715,531,21,3018,4.60,5.31,19.06,5.55
2021-09-24,2021-10-01,Auto-immune diseases,Guillain-Barré Syndrome,33,18,31,0,82,0.09,0.13,1.11,0.15
2021-09-24,2021-10-01,Auto-immune diseases,Thrombocytopenia (low blood platelets),17,8,36,3,64,0.04,0.06,1.29,0.12
2021-09-24,2021-10-01,Auto-immune diseases,Subtotal n (%),50,26,67,3,146,0.13,0.19,2.40,0.27
2021-09-24,2021-10-01,Cardiovascular system,Cardiac arrest,10,9,5,0,24,0.03,0.07,0.18,0.04
2021-09-24,2021-10-01,Cardiovascular system,Cardiac failure,19,5,3,1,28,0.05,0.04,0.11,0.05
2021-09-24,2021-10-01,Cardiovascular system,Myocardial infarction (heart attack),46,16,6,4,72,0.12,0.12,0.22,0.13
2021-09-24,2021-10-01,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),466,321,21,4,812,1.21,2.36,0.75,1.48
2021-09-24,2021-10-01,Cardiovascular system,Subtotal n (%),541,351,35,9,936,1.40,2.58,1.26,1.70
2021-09-24,2021-10-01,Circulatory system,Cerebral venous (sinus) thrombosis,2,1,11,0,14,0.01,0.01,0.39,0.03
2021-09-24,2021-10-01,Circulatory system,Cerebral thrombosis ,4,2,1,0,7,0.01,0.01,0.04,0.01
2021-09-24,2021-10-01,Circulatory system,Cutaneous vasculitis,12,5,4,0,21,0.03,0.04,0.14,0.04
2021-09-24,2021-10-01,Circulatory system,Deep vein thrombosis,115,36,53,0,204,0.30,0.26,1.90,0.37
2021-09-24,2021-10-01,Circulatory system,Embolism,3,1,7,0,11,0.01,0.01,0.25,0.02
2021-09-24,2021-10-01,Circulatory system,Haemorrhage (bleeding),24,9,9,1,43,0.06,0.07,0.32,0.08
2021-09-24,2021-10-01,Circulatory system,Pulmonary embolism,141,52,108,0,301,0.37,0.38,3.87,0.55
2021-09-24,2021-10-01,Circulatory system,Thrombosis (blood clot),86,24,78,1,189,0.22,0.18,2.80,0.34
2021-09-24,2021-10-01,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),16,5,61,0,82,0.04,0.04,2.19,0.15
2021-09-24,2021-10-01,Circulatory system,Subtotal n (%),403,135,332,2,872,1.05,0.99,11.91,1.59
2021-09-24,2021-10-01,Hepato-gastrointestinal and renal system,Acute kidney injury,16,12,3,0,31,0.04,0.09,0.11,0.06
2021-09-24,2021-10-01,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),4,1,1,0,6,0.01,0.01,0.04,0.01
2021-09-24,2021-10-01,Hepato-gastrointestinal and renal system,Liver injury,12,6,3,0,21,0.03,0.04,0.11,0.04
2021-09-24,2021-10-01,Hepato-gastrointestinal and renal system,Subtotal n (%),29,19,6,0,54,0.08,0.14,0.22,0.10
2021-09-24,2021-10-01,Nerves and central nervous system,Bell's Palsy/facial paralysis*,364,117,44,1,526,0.94,0.86,1.58,0.96
2021-09-24,2021-10-01,Nerves and central nervous system,Cerebrovascular accident (stroke),79,28,34,3,144,0.20,0.21,1.22,0.26
2021-09-24,2021-10-01,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),18,5,4,0,27,0.05,0.04,0.14,0.05
2021-09-24,2021-10-01,Nerves and central nervous system,Subtotal n (%),461,150,82,4,697,1.20,1.10,2.94,1.27
2021-09-24,2021-10-01,Other system,Anaphylaxis*,202,54,12,0,268,0.52,0.40,0.43,0.49
2021-09-24,2021-10-01,Other system,COVID-19*,111,5,2,5,123,0.29,0.04,0.07,0.22
2021-09-24,2021-10-01,Other system,Multisystem inflammatory syndrome,1,1,0,0,2,0.00,0.01,0.00,0.00
2021-09-24,2021-10-01,Other system,Subtotal n (%),314,60,14,5,393,0.81,0.44,0.50,0.71
2021-09-24,2021-10-01,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-09-24,2021-10-01,Pregnancy outcomes,Spontaneous abortion,28,7,1,0,36,0.07,0.05,0.04,0.07
2021-09-24,2021-10-01,Pregnancy outcomes,Subtotal n (%),33,7,1,0,41,0.09,0.05,0.04,0.07
2021-09-24,2021-10-01,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-09-24,2021-10-01,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-09-24,2021-10-01,"Skin and mucous membrane, bone and joints system",Chilblains,9,3,1,0,13,0.02,0.02,0.04,0.02
2021-09-24,2021-10-01,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),13,9,1,0,23,0.03,0.07,0.04,0.04
2021-09-24,2021-10-01,"Skin and mucous membrane, bone and joints system",Subtotal n (%),22,12,2,0,36,0.06,0.09,0.07,0.07
2021-09-24,2021-10-01,All AESI categories,TOTAL,1855,761,539,23,3178,4.81,5.59,19.33,5.78
2021-10-01,2021-10-08,Auto-immune diseases,Guillain-Barré Syndrome,33,19,31,0,83,0.08,0.14,1.11,0.15
2021-10-01,2021-10-08,Auto-immune diseases,Thrombocytopenia (low blood platelets),18,8,36,3,65,0.05,0.06,1.29,0.12
2021-10-01,2021-10-08,Auto-immune diseases,Subtotal n (%),51,27,67,3,148,0.13,0.20,2.40,0.27
2021-10-01,2021-10-08,Cardiovascular system,Cardiac arrest,11,9,5,0,25,0.03,0.07,0.18,0.05
2021-10-01,2021-10-08,Cardiovascular system,Cardiac failure,19,5,3,1,28,0.05,0.04,0.11,0.05
2021-10-01,2021-10-08,Cardiovascular system,Myocardial infarction (heart attack),47,16,6,4,73,0.12,0.12,0.22,0.13
2021-10-01,2021-10-08,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),501,333,20,5,859,1.28,2.44,0.72,1.55
2021-10-01,2021-10-08,Cardiovascular system,Subtotal n (%),578,363,34,10,985,1.48,2.66,1.22,1.77
2021-10-01,2021-10-08,Circulatory system,Cerebral venous (sinus) thrombosis,3,0,8,0,11,0.01,0.00,0.29,0.02
2021-10-01,2021-10-08,Circulatory system,Cerebral thrombosis,4,2,1,0,7,0.01,0.01,0.04,0.01
2021-10-01,2021-10-08,Circulatory system,Cutaneous vasculitis,12,5,4,0,21,0.03,0.04,0.14,0.04
2021-10-01,2021-10-08,Circulatory system,Deep vein thrombosis,117,37,54,0,208,0.30,0.27,1.94,0.37
2021-10-01,2021-10-08,Circulatory system,Embolism,3,1,7,0,11,0.01,0.01,0.25,0.02
2021-10-01,2021-10-08,Circulatory system,Haemorrhage (bleeding),25,9,9,1,44,0.06,0.07,0.32,0.08
2021-10-01,2021-10-08,Circulatory system,Pulmonary embolism,144,54,110,0,308,0.37,0.40,3.94,0.55
2021-10-01,2021-10-08,Circulatory system,Thrombosis (blood clot),94,25,79,2,200,0.24,0.18,2.83,0.36
2021-10-01,2021-10-08,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),16,5,61,0,82,0.04,0.04,2.19,0.15
2021-10-01,2021-10-08,Circulatory system,Subtotal n (%),418,138,333,3,892,1.07,1.01,11.94,1.61
2021-10-01,2021-10-08,Hepato-gastrointestinal and renal system,Acute kidney injury,17,12,3,0,32,0.04,0.09,0.11,0.06
2021-10-01,2021-10-08,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),4,2,0,0,6,0.01,0.01,0.00,0.01
2021-10-01,2021-10-08,Hepato-gastrointestinal and renal system,Liver injury,12,6,3,0,21,0.03,0.04,0.11,0.04
2021-10-01,2021-10-08,Hepato-gastrointestinal and renal system,Subtotal n (%),33,20,6,0,59,0.08,0.15,0.22,0.11
2021-10-01,2021-10-08,Nerves and central nervous system,Bell's Palsy/facial paralysis*,378,121,44,2,545,0.97,0.89,1.58,0.98
2021-10-01,2021-10-08,Nerves and central nervous system,Cerebrovascular accident (stroke),83,28,34,3,148,0.21,0.21,1.22,0.27
2021-10-01,2021-10-08,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),19,5,4,0,28,0.05,0.04,0.14,0.05
2021-10-01,2021-10-08,Nerves and central nervous system,Subtotal n (%),480,154,82,5,721,1.23,1.13,2.94,1.30
2021-10-01,2021-10-08,Other system,Anaphylaxis*,233,61,13,0,307,0.60,0.45,0.47,0.55
2021-10-01,2021-10-08,Other system,COVID-19*,112,6,2,6,126,0.29,0.04,0.07,0.23
2021-10-01,2021-10-08,Other system,Multisystem inflammatory syndrome,1,1,0,0,2,0.00,0.01,0.00,0.00
2021-10-01,2021-10-08,Other system,Subtotal n (%),346,68,15,6,435,0.89,0.50,0.54,0.78
2021-10-01,2021-10-08,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-10-01,2021-10-08,Pregnancy outcomes,Spontaneous abortion,29,7,1,0,37,0.07,0.05,0.04,0.07
2021-10-01,2021-10-08,Pregnancy outcomes,Subtotal n (%),34,7,1,0,42,0.09,0.05,0.04,0.08
2021-10-01,2021-10-08,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-10-01,2021-10-08,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-10-01,2021-10-08,"Skin and mucous membrane, bone and joints system",Chilblains,9,3,1,0,13,0.02,0.02,0.04,0.02
2021-10-01,2021-10-08,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),14,9,1,0,24,0.04,0.07,0.04,0.04
2021-10-01,2021-10-08,"Skin and mucous membrane, bone and joints system",Subtotal n (%),23,12,2,0,37,0.06,0.09,0.07,0.07
2021-10-01,2021-10-08,All AESI categories,TOTAL,1965,790,540,27,3322,5.03,5.79,19.36,5.98
2021-10-08,2021-10-18,Auto-immune diseases,Guillain-Barré Syndrome,34,19,32,0,85,0.09,0.14,1.15,0.15
2021-10-08,2021-10-18,Auto-immune diseases,Thrombocytopenia (low blood platelets),18,8,35,3,64,0.05,0.06,1.25,0.11
2021-10-08,2021-10-18,Auto-immune diseases,Subtotal n (%),52,27,67,3,149,0.13,0.19,2.40,0.27
2021-10-08,2021-10-18,Cardiovascular system,Cardiac arrest,13,10,5,0,28,0.03,0.07,0.18,0.05
2021-10-08,2021-10-18,Cardiovascular system,Cardiac failure,19,7,3,1,30,0.05,0.05,0.11,0.05
2021-10-08,2021-10-18,Cardiovascular system,Myocardial infarction (heart attack),47,16,6,4,73,0.12,0.12,0.22,0.13
2021-10-08,2021-10-18,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),540,348,20,5,913,1.37,2.51,0.72,1.62
2021-10-08,2021-10-18,Cardiovascular system,Subtotal n (%),619,381,34,10,1044,1.57,2.74,1.22,1.86
2021-10-08,2021-10-18,Circulatory system,Cerebral venous (sinus) thrombosis,3,1,11,0,15,0.01,0.01,0.39,0.03
2021-10-08,2021-10-18,Circulatory system,Cerebral thrombosis ,4,2,1,0,7,0.01,0.01,0.04,0.01
2021-10-08,2021-10-18,Circulatory system,Cutaneous vasculitis,14,5,4,0,23,0.04,0.04,0.14,0.04
2021-10-08,2021-10-18,Circulatory system,Deep vein thrombosis,117,37,55,0,209,0.30,0.27,1.97,0.37
2021-10-08,2021-10-18,Circulatory system,Embolism,3,1,7,0,11,0.01,0.01,0.25,0.02
2021-10-08,2021-10-18,Circulatory system,Haemorrhage (bleeding),27,10,9,1,47,0.07,0.07,0.32,0.08
2021-10-08,2021-10-18,Circulatory system,Pulmonary embolism,150,56,111,0,317,0.38,0.40,3.98,0.56
2021-10-08,2021-10-18,Circulatory system,Thrombosis (blood clot),98,25,79,2,204,0.25,0.18,2.83,0.36
2021-10-08,2021-10-18,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),16,5,61,0,82,0.04,0.04,2.19,0.15
2021-10-08,2021-10-18,Circulatory system,Subtotal n (%),432,142,338,3,915,1.09,1.02,12.11,1.63
2021-10-08,2021-10-18,Hepato-gastrointestinal and renal system,Acute kidney injury,17,12,3,0,32,0.04,0.09,0.11,0.06
2021-10-08,2021-10-18,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),4,1,0,0,5,0.01,0.01,0.00,0.01
2021-10-08,2021-10-18,Hepato-gastrointestinal and renal system,Liver injury,14,8,3,0,25,0.04,0.06,0.11,0.04
2021-10-08,2021-10-18,Hepato-gastrointestinal and renal system,Subtotal n (%),35,21,6,0,62,0.09,0.15,0.22,0.11
2021-10-08,2021-10-18,Nerves and central nervous system,Bell's Palsy/facial paralysis*,396,122,44,2,564,1.00,0.88,1.58,1.00
2021-10-08,2021-10-18,Nerves and central nervous system,Cerebrovascular accident (stroke),85,29,34,3,151,0.22,0.21,1.22,0.27
2021-10-08,2021-10-18,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),19,7,4,0,30,0.05,0.05,0.14,0.05
2021-10-08,2021-10-18,Nerves and central nervous system,Subtotal n (%),500,158,82,5,745,1.27,1.14,2.94,1.33
2021-10-08,2021-10-18,Other system,Anaphylaxis*,278,74,16,0,368,0.70,0.53,0.57,0.65
2021-10-08,2021-10-18,Other system,COVID-19*,120,6,2,6,134,0.30,0.04,0.07,0.24
2021-10-08,2021-10-18,Other system,Multisystem inflammatory syndrome,1,1,0,0,2,0.00,0.01,0.00,0.00
2021-10-08,2021-10-18,Other system,Subtotal n (%),399,81,18,6,504,1.01,0.58,0.65,0.90
2021-10-08,2021-10-18,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-10-08,2021-10-18,Pregnancy outcomes,Spontaneous abortion,29,7,1,0,37,0.07,0.05,0.04,0.07
2021-10-08,2021-10-18,Pregnancy outcomes,Subtotal n (%),34,7,1,0,42,0.09,0.05,0.04,0.07
2021-10-08,2021-10-18,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-10-08,2021-10-18,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-10-08,2021-10-18,"Skin and mucous membrane, bone and joints system",Chilblains,9,3,1,0,13,0.02,0.02,0.04,0.02
2021-10-08,2021-10-18,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),14,9,1,0,24,0.04,0.06,0.04,0.04
2021-10-08,2021-10-18,"Skin and mucous membrane, bone and joints system",Subtotal n (%),23,12,2,0,37,0.06,0.09,0.07,0.07
2021-10-08,2021-10-18,All AESI categories,TOTAL,2096,830,548,27,3501,5.31,5.98,19.64,6.23
2021-10-15,2021-10-22,Auto-immune diseases,Guillain-Barré Syndrome,34,19,32,0,85,0.09,0.14,1.15,0.15
2021-10-15,2021-10-22,Auto-immune diseases,Thrombocytopenia (low blood platelets),19,8,35,3,65,0.05,0.06,1.25,0.11
2021-10-15,2021-10-22,Auto-immune diseases,Subtotal n (%),53,27,67,3,150,0.13,0.19,2.40,0.26
2021-10-15,2021-10-22,Cardiovascular system,Cardiac arrest,16,10,5,0,31,0.04,0.07,0.18,0.05
2021-10-15,2021-10-22,Cardiovascular system,Cardiac failure,19,8,3,1,31,0.05,0.06,0.11,0.05
2021-10-15,2021-10-22,Cardiovascular system,Myocardial infarction (heart attack),48,18,6,4,76,0.12,0.13,0.21,0.13
2021-10-15,2021-10-22,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),573,357,21,5,956,1.44,2.55,0.75,1.68
2021-10-15,2021-10-22,Cardiovascular system,Subtotal n (%),656,393,35,10,1094,1.64,2.80,1.25,1.93
2021-10-15,2021-10-22,Circulatory system,Cerebral venous (sinus) thrombosis,3,1,11,0,15,0.01,0.01,0.39,0.03
2021-10-15,2021-10-22,Circulatory system,Cerebral thrombosis ,5,2,1,0,8,0.01,0.01,0.04,0.01
2021-10-15,2021-10-22,Circulatory system,Cutaneous vasculitis,15,6,4,0,25,0.04,0.04,0.14,0.04
2021-10-15,2021-10-22,Circulatory system,Deep vein thrombosis,118,38,56,0,212,0.30,0.27,2.01,0.37
2021-10-15,2021-10-22,Circulatory system,Embolism,3,1,7,0,11,0.01,0.01,0.25,0.02
2021-10-15,2021-10-22,Circulatory system,Haemorrhage (bleeding),29,10,9,1,49,0.07,0.07,0.32,0.09
2021-10-15,2021-10-22,Circulatory system,Pulmonary embolism,152,57,112,0,321,0.38,0.41,4.01,0.57
2021-10-15,2021-10-22,Circulatory system,Thrombosis (blood clot),102,25,80,2,209,0.26,0.18,2.87,0.37
2021-10-15,2021-10-22,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),16,5,61,0,82,0.04,0.04,2.18,0.14
2021-10-15,2021-10-22,Circulatory system,Subtotal n (%),443,145,341,3,932,1.11,1.03,12.21,1.64
2021-10-15,2021-10-22,Hepato-gastrointestinal and renal system,Acute kidney injury,18,14,3,0,35,0.05,0.10,0.11,0.06
2021-10-15,2021-10-22,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),4,1,0,0,5,0.01,0.01,0.00,0.01
2021-10-15,2021-10-22,Hepato-gastrointestinal and renal system,Liver injury,14,8,3,0,25,0.04,0.06,0.11,0.04
2021-10-15,2021-10-22,Hepato-gastrointestinal and renal system,Subtotal n (%),36,23,6,0,65,0.09,0.16,0.21,0.11
2021-10-15,2021-10-22,Nerves and central nervous system,Bell's Palsy/facial paralysis*,406,122,44,2,574,1.02,0.87,1.58,1.01
2021-10-15,2021-10-22,Nerves and central nervous system,Cerebrovascular accident (stroke),85,30,34,3,152,0.21,0.21,1.22,0.27
2021-10-15,2021-10-22,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),20,7,4,0,31,0.05,0.05,0.14,0.05
2021-10-15,2021-10-22,Nerves and central nervous system,Subtotal n (%),511,159,82,5,757,1.28,1.13,2.94,1.33
2021-10-15,2021-10-22,Other system,Anaphylaxis*,314,89,16,0,419,0.79,0.64,0.57,0.74
2021-10-15,2021-10-22,Other system,COVID-19*,122,6,2,8,138,0.31,0.04,0.07,0.24
2021-10-15,2021-10-22,Other system,Multisystem inflammatory syndrome,1,1,0,0,2,0.00,0.01,0.00,0.00
2021-10-15,2021-10-22,Other system,Subtotal n (%),437,96,18,8,559,1.10,0.69,0.64,0.99
2021-10-15,2021-10-22,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-10-15,2021-10-22,Pregnancy outcomes,Spontaneous abortion,30,7,1,0,38,0.08,0.05,0.04,0.07
2021-10-15,2021-10-22,Pregnancy outcomes,Subtotal n (%),35,7,1,0,43,0.09,0.05,0.04,0.08
2021-10-15,2021-10-22,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.01,0.01,0.00,0.01
2021-10-15,2021-10-22,Respiratory system,Subtotal n (%),2,1,0,0,3,0.01,0.01,0.00,0.01
2021-10-15,2021-10-22,"Skin and mucous membrane, bone and joints system",Chilblains,8,3,1,0,12,0.02,0.02,0.04,0.02
2021-10-15,2021-10-22,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),17,10,1,0,28,0.04,0.07,0.04,0.05
2021-10-15,2021-10-22,"Skin and mucous membrane, bone and joints system",Subtotal n (%),25,13,2,0,40,0.06,0.09,0.07,0.07
2021-10-15,2021-10-22,All AESI categories,TOTAL,2198,864,552,29,3643,5.51,6.17,19.77,6.42
2021-10-22,2021-10-29,Auto-immune diseases,Guillain-Barré Syndrome,41,21,35,0,97,0.10,0.15,1.25,0.17
2021-10-22,2021-10-29,Auto-immune diseases,Thrombocytopenia (low blood platelets),20,10,36,3,69,0.05,0.07,1.29,0.12
2021-10-22,2021-10-29,Auto-immune diseases,Subtotal n (%),61,31,71,3,166,0.15,0.22,2.54,0.29
2021-10-22,2021-10-29,Cardiovascular system,Cardiac arrest,17,10,5,0,32,0.04,0.07,0.18,0.06
2021-10-22,2021-10-29,Cardiovascular system,Cardiac failure,20,8,3,1,32,0.05,0.06,0.11,0.06
2021-10-22,2021-10-29,Cardiovascular system,Myocardial infarction (heart attack),50,18,6,3,77,0.12,0.13,0.21,0.13
2021-10-22,2021-10-29,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),584,360,21,5,970,1.45,2.55,0.75,1.69
2021-10-22,2021-10-29,Cardiovascular system,Subtotal n (%),671,396,35,9,1111,1.67,2.80,1.25,1.94
2021-10-22,2021-10-29,Circulatory system,Cerebral venous (sinus) thrombosis,3,2,10,0,15,0.01,0.01,0.36,0.03
2021-10-22,2021-10-29,Circulatory system,Cerebral thrombosis ,5,3,1,0,9,0.01,0.02,0.04,0.02
2021-10-22,2021-10-29,Circulatory system,Cutaneous vasculitis,15,6,4,0,25,0.04,0.04,0.14,0.04
2021-10-22,2021-10-29,Circulatory system,Deep vein thrombosis,121,39,58,0,218,0.30,0.28,2.08,0.38
2021-10-22,2021-10-29,Circulatory system,Embolism,3,3,7,0,13,0.01,0.02,0.25,0.02
2021-10-22,2021-10-29,Circulatory system,Haemorrhage (bleeding),29,10,9,1,49,0.07,0.07,0.32,0.09
2021-10-22,2021-10-29,Circulatory system,Pulmonary embolism,152,57,112,0,321,0.38,0.40,4.01,0.56
2021-10-22,2021-10-29,Circulatory system,Thrombosis (blood clot),106,26,80,2,214,0.26,0.18,2.86,0.37
2021-10-22,2021-10-29,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),16,6,61,0,83,0.04,0.04,2.18,0.15
2021-10-22,2021-10-29,Circulatory system,Subtotal n (%),450,152,342,3,947,1.12,1.08,12.24,1.65
2021-10-22,2021-10-29,Hepato-gastrointestinal and renal system,Acute kidney injury,20,14,3,0,37,0.05,0.10,0.11,0.06
2021-10-22,2021-10-29,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),4,1,0,0,5,0.01,0.01,0.00,0.01
2021-10-22,2021-10-29,Hepato-gastrointestinal and renal system,Liver injury,14,8,3,0,25,0.03,0.06,0.11,0.04
2021-10-22,2021-10-29,Hepato-gastrointestinal and renal system,Subtotal n (%),38,23,6,0,67,0.09,0.16,0.21,0.12
2021-10-22,2021-10-29,Nerves and central nervous system,Bell's Palsy/facial paralysis*,416,132,45,1,594,1.03,0.93,1.61,1.04
2021-10-22,2021-10-29,Nerves and central nervous system,Cerebrovascular accident (stroke),87,31,34,3,155,0.22,0.22,1.22,0.27
2021-10-22,2021-10-29,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),20,7,5,0,32,0.05,0.05,0.18,0.06
2021-10-22,2021-10-29,Nerves and central nervous system,Subtotal n (%),523,170,84,4,781,1.30,0.42,0.21,0.01
2021-10-22,2021-10-29,Other system,Anaphylaxis*,371,97,19,0,487,0.92,0.69,0.68,0.85
2021-10-22,2021-10-29,Other system,COVID-19*,128,6,1,9,144,0.32,0.04,0.04,0.25
2021-10-22,2021-10-29,Other system,Multisystem inflammatory syndrome,2,1,0,0,3,0.00,0.01,0.00,0.01
2021-10-22,2021-10-29,Other system,Subtotal n (%),501,104,20,9,634,1.24,0.74,0.72,1.11
2021-10-22,2021-10-29,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-10-22,2021-10-29,Pregnancy outcomes,Spontaneous abortion,30,7,1,0,38,0.07,0.05,0.04,0.07
2021-10-22,2021-10-29,Pregnancy outcomes,Subtotal n (%),35,7,1,0,43,0.09,0.05,0.04,0.08
2021-10-22,2021-10-29,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.00,0.01,0.00,0.01
2021-10-22,2021-10-29,Respiratory system,Subtotal n (%),2,1,0,0,3,0.00,0.01,0.00,0.01
2021-10-22,2021-10-29,"Skin and mucous membrane, bone and joints system",Chilblains,9,3,1,0,13,0.02,0.02,0.04,0.02
2021-10-22,2021-10-29,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),17,10,1,0,28,0.04,0.07,0.04,0.05
2021-10-22,2021-10-29,"Skin and mucous membrane, bone and joints system",Subtotal n (%),26,13,2,0,41,0.06,0.09,0.07,0.07
2021-10-22,2021-10-29,All AESI categories,TOTAL,2307,897,561,28,3793,5.73,6.35,20.08,6.63
2021-10-29,2021-11-05,Auto-immune diseases,Guillain-Barré Syndrome,41,21,35,0,97,0.10,0.15,1.25,0.17
2021-10-29,2021-11-05,Auto-immune diseases,Thrombocytopenia (low blood platelets),21,10,38,3,72,0.05,0.07,1.36,0.12
2021-10-29,2021-11-05,Auto-immune diseases,Subtotal n (%),62,31,73,3,169,0.15,0.22,2.61,0.29
2021-10-29,2021-11-05,Cardiovascular system,Cardiac arrest,18,10,5,0,33,0.04,0.07,0.18,0.06
2021-10-29,2021-11-05,Cardiovascular system,Cardiac failure,21,9,3,1,34,0.05,0.06,0.11,0.06
2021-10-29,2021-11-05,Cardiovascular system,Myocardial infarction (heart attack),52,18,6,3,79,0.13,0.13,0.21,0.14
2021-10-29,2021-11-05,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),613,374,21,4,1012,1.51,2.62,0.75,1.75
2021-10-29,2021-11-05,Cardiovascular system,Subtotal n (%),704,411,35,8,1158,1.73,2.88,1.25,2.01
2021-10-29,2021-11-05,Circulatory system,Cerebral venous (sinus) thrombosis,3,1,11,0,15,0.01,0.01,0.39,0.03
2021-10-29,2021-11-05,Circulatory system,Cerebral thrombosis ,6,3,1,1,11,0.01,0.02,0.04,0.02
2021-10-29,2021-11-05,Circulatory system,Cutaneous vasculitis,15,6,4,0,25,0.04,0.04,0.14,0.04
2021-10-29,2021-11-05,Circulatory system,Deep vein thrombosis,124,40,59,0,223,0.31,0.28,2.11,0.39
2021-10-29,2021-11-05,Circulatory system,Embolism,3,3,7,0,13,0.01,0.02,0.25,0.02
2021-10-29,2021-11-05,Circulatory system,Haemorrhage (bleeding),30,10,9,2,51,0.07,0.07,0.32,0.09
2021-10-29,2021-11-05,Circulatory system,Pulmonary embolism,154,57,114,0,325,0.38,0.40,4.08,0.56
2021-10-29,2021-11-05,Circulatory system,Thrombosis (blood clot),114,26,82,2,224,0.28,0.18,2.93,0.39
2021-10-29,2021-11-05,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),18,6,63,0,87,0.04,0.04,2.25,0.15
2021-10-29,2021-11-05,Circulatory system,Subtotal n (%),467,152,350,5,974,1.15,1.07,12.52,1.69
2021-10-29,2021-11-05,Hepato-gastrointestinal and renal system,Acute kidney injury,21,14,3,0,38,0.05,0.10,0.11,0.07
2021-10-29,2021-11-05,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),6,1,0,0,7,0.01,0.01,0.00,0.01
2021-10-29,2021-11-05,Hepato-gastrointestinal and renal system,Liver injury,15,8,3,0,26,0.04,0.06,0.11,0.05
2021-10-29,2021-11-05,Hepato-gastrointestinal and renal system,Subtotal n (%),42,23,6,0,71,0.10,0.16,0.21,0.12
2021-10-29,2021-11-05,Nerves and central nervous system,Bell's Palsy/facial paralysis*,427,138,45,1,611,1.05,0.97,1.61,1.06
2021-10-29,2021-11-05,Nerves and central nervous system,Cerebrovascular accident (stroke),87,31,34,3,155,0.21,0.22,1.22,0.27
2021-10-29,2021-11-05,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),20,8,5,0,33,0.05,0.06,0.18,0.06
2021-10-29,2021-11-05,Nerves and central nervous system,Subtotal n (%),534,177,84,4,799,1.31,1.24,3.01,1.38
2021-10-29,2021-11-05,Other system,Anaphylaxis*,406,111,21,1,539,1.00,0.78,0.75,0.93
2021-10-29,2021-11-05,Other system,COVID-19*,130,6,1,10,147,0.32,0.04,0.04,0.25
2021-10-29,2021-11-05,Other system,Multisystem inflammatory syndrome,3,1,0,0,4,0.01,0.01,0.00,0.01
2021-10-29,2021-11-05,Other system,Subtotal n (%),539,118,22,11,690,1.33,0.83,0.79,1.19
2021-10-29,2021-11-05,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-10-29,2021-11-05,Pregnancy outcomes,Spontaneous abortion,32,7,1,0,40,0.08,0.05,0.04,0.07
2021-10-29,2021-11-05,Pregnancy outcomes,Subtotal n (%),37,7,1,0,45,0.09,0.05,0.04,0.08
2021-10-29,2021-11-05,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.00,0.01,0.00,0.01
2021-10-29,2021-11-05,Respiratory system,Subtotal n (%),2,1,0,0,3,0.00,0.01,0.00,0.01
2021-10-29,2021-11-05,"Skin and mucous membrane, bone and joints system",Chilblains,9,3,1,0,13,0.02,0.02,0.04,0.02
2021-10-29,2021-11-05,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),17,10,1,0,28,0.04,0.07,0.04,0.05
2021-10-29,2021-11-05,"Skin and mucous membrane, bone and joints system",Subtotal n (%),26,13,2,0,41,0.06,0.09,0.07,0.07
2021-10-29,2021-11-05,All AESI categories,TOTAL,2413,933,573,31,3950,5.94,6.55,20.50,6.84
2021-11-05,2021-11-15,Auto-immune diseases,Guillain-Barré Syndrome,42,22,36,0,100,0.10,0.15,1.29,0.17
2021-11-05,2021-11-15,Auto-immune diseases,Thrombocytopenia (low blood platelets),23,10,39,3,75,0.06,0.07,1.39,0.13
2021-11-05,2021-11-15,Auto-immune diseases,Subtotal n (%),65,32,75,3,175,0.16,0.22,2.68,0.30
2021-11-05,2021-11-15,Cardiovascular system,Cardiac arrest,18,10,5,0,33,0.04,0.07,0.18,0.06
2021-11-05,2021-11-15,Cardiovascular system,Cardiac failure,21,9,3,1,34,0.05,0.06,0.11,0.06
2021-11-05,2021-11-15,Cardiovascular system,Myocardial infarction (heart attack),53,20,6,3,82,0.13,0.14,0.21,0.14
2021-11-05,2021-11-15,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),654,396,21,4,1075,1.60,2.76,0.75,1.85
2021-11-05,2021-11-15,Cardiovascular system,Subtotal n (%),746,435,35,8,1224,1.82,3.03,1.25,2.11
2021-11-05,2021-11-15,Circulatory system,Cerebral venous (sinus) thrombosis,3,1,11,0,15,0.01,0.01,0.39,0.03
2021-11-05,2021-11-15,Circulatory system,Cerebral thrombosis ,6,3,1,1,11,0.01,0.02,0.04,0.02
2021-11-05,2021-11-15,Circulatory system,Cutaneous vasculitis,15,7,4,0,26,0.04,0.05,0.14,0.04
2021-11-05,2021-11-15,Circulatory system,Deep vein thrombosis,124,41,60,0,225,0.30,0.29,2.15,0.39
2021-11-05,2021-11-15,Circulatory system,Embolism,3,3,7,0,13,0.01,0.02,0.25,0.02
2021-11-05,2021-11-15,Circulatory system,Haemorrhage (bleeding),30,10,9,2,51,0.07,0.07,0.32,0.09
2021-11-05,2021-11-15,Circulatory system,Pulmonary embolism,161,59,114,0,334,0.39,0.41,4.08,0.57
2021-11-05,2021-11-15,Circulatory system,Thrombosis (blood clot),118,26,82,2,228,0.29,0.18,2.93,0.39
2021-11-05,2021-11-15,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),19,6,63,0,88,0.05,0.04,2.25,0.15
2021-11-05,2021-11-15,Circulatory system,Subtotal n (%),479,156,351,5,991,1.17,1.09,12.55,1.70
2021-11-05,2021-11-15,Hepato-gastrointestinal and renal system,Acute kidney injury,22,14,3,0,39,0.05,0.10,0.11,0.07
2021-11-05,2021-11-15,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),6,1,0,0,7,0.01,0.01,0.00,0.01
2021-11-05,2021-11-15,Hepato-gastrointestinal and renal system,Liver injury,16,8,3,0,27,0.04,0.06,0.11,0.05
2021-11-05,2021-11-15,Hepato-gastrointestinal and renal system,Subtotal n (%),44,23,6,0,73,0.11,0.16,0.21,0.13
2021-11-05,2021-11-15,Nerves and central nervous system,Bell's Palsy/facial paralysis*,440,139,45,1,625,1.07,0.97,1.61,1.08
2021-11-05,2021-11-15,Nerves and central nervous system,Cerebrovascular accident (stroke),87,33,34,3,157,0.21,0.23,1.22,0.27
2021-11-05,2021-11-15,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),21,8,5,0,34,0.05,0.06,0.18,0.06
2021-11-05,2021-11-15,Nerves and central nervous system,Subtotal n (%),548,180,84,4,816,1.34,1.25,3.00,1.40
2021-11-05,2021-11-15,Other system,Anaphylaxis*,441,125,21,1,588,1.08,0.87,0.75,1.01
2021-11-05,2021-11-15,Other system,COVID-19*,133,6,1,10,150,0.32,0.04,0.04,0.26
2021-11-05,2021-11-15,Other system,Multisystem inflammatory syndrome,4,1,0,0,5,0.01,0.01,0.00,0.01
2021-11-05,2021-11-15,Other system,Subtotal n (%),578,132,22,11,743,1.41,0.92,0.79,1.28
2021-11-05,2021-11-15,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-11-05,2021-11-15,Pregnancy outcomes,Spontaneous abortion,34,9,1,0,44,0.08,0.06,0.04,0.08
2021-11-05,2021-11-15,Pregnancy outcomes,Subtotal n (%),39,9,1,0,49,0.10,0.06,0.04,0.08
2021-11-05,2021-11-15,Respiratory system,Acute respiratory distress syndrome,2,1,0,0,3,0.00,0.01,0.00,0.01
2021-11-05,2021-11-15,Respiratory system,Subtotal n (%),2,1,0,0,3,0.00,0.01,0.00,0.01
2021-11-05,2021-11-15,"Skin and mucous membrane, bone and joints system",Chilblains,10,3,1,0,14,0.02,0.02,0.04,0.02
2021-11-05,2021-11-15,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),18,10,1,0,29,0.04,0.07,0.04,0.05
2021-11-05,2021-11-15,"Skin and mucous membrane, bone and joints system",Subtotal n (%),28,13,2,0,43,0.07,0.09,0.07,0.07
2021-11-05,2021-11-15,All AESI categories,TOTAL,2529,981,576,31,4117,6.18,6.83,20.60,7.08
2021-11-12,2021-11-19,Auto-immune diseases,Guillain-Barré Syndrome,44,22,37,0,103,0.11,0.15,1.32,0.18
2021-11-12,2021-11-19,Auto-immune diseases,Thrombocytopenia (low blood platelets),21,10,39,3,73,0.05,0.07,1.39,0.12
2021-11-12,2021-11-19,Auto-immune diseases,Subtotal n (%),65,32,76,3,176,0.16,0.22,2.72,0.30
2021-11-12,2021-11-19,Cardiovascular system,Cardiac arrest,18,10,5,0,33,0.04,0.07,0.18,0.06
2021-11-12,2021-11-19,Cardiovascular system,Cardiac failure,21,9,4,1,35,0.05,0.06,0.14,0.06
2021-11-12,2021-11-19,Cardiovascular system,Myocardial infarction (heart attack),55,20,6,3,84,0.13,0.14,0.21,0.14
2021-11-12,2021-11-19,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),775,439,24,3,1241,1.88,3.03,0.86,2.12
2021-11-12,2021-11-19,Cardiovascular system,Subtotal n (%),869,478,39,7,1393,2.10,3.30,1.39,2.38
2021-11-12,2021-11-19,Circulatory system,Cerebral venous (sinus) thrombosis,3,1,11,0,15,0.01,0.01,0.39,0.03
2021-11-12,2021-11-19,Circulatory system,Cerebral thrombosis ,5,4,1,1,11,0.01,0.03,0.04,0.02
2021-11-12,2021-11-19,Circulatory system,Cutaneous vasculitis,16,7,4,0,27,0.04,0.05,0.14,0.05
2021-11-12,2021-11-19,Circulatory system,Deep vein thrombosis,126,44,61,0,231,0.30,0.30,2.18,0.39
2021-11-12,2021-11-19,Circulatory system,Embolism,3,3,7,0,13,0.01,0.02,0.25,0.02
2021-11-12,2021-11-19,Circulatory system,Haemorrhage (bleeding),31,11,8,2,52,0.08,0.08,0.29,0.09
2021-11-12,2021-11-19,Circulatory system,Pulmonary embolism,170,62,117,0,349,0.41,0.43,4.18,0.60
2021-11-12,2021-11-19,Circulatory system,Thrombosis (blood clot),119,27,86,2,234,0.29,0.19,3.08,0.40
2021-11-12,2021-11-19,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),19,6,64,0,89,0.05,0.04,2.29,0.15
2021-11-12,2021-11-19,Circulatory system,Subtotal n (%),492,165,359,5,1021,1.19,1.14,12.84,1.74
2021-11-12,2021-11-19,Hepato-gastrointestinal and renal system,Acute kidney injury,23,14,4,0,41,0.06,0.10,0.14,0.07
2021-11-12,2021-11-19,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),6,1,0,0,7,0.01,0.01,0.00,0.01
2021-11-12,2021-11-19,Hepato-gastrointestinal and renal system,Liver injury,17,8,3,0,28,0.04,0.06,0.11,0.05
2021-11-12,2021-11-19,Hepato-gastrointestinal and renal system,Subtotal n (%),46,23,7,0,76,0.11,0.16,0.25,0.13
2021-11-12,2021-11-19,Nerves and central nervous system,Bell's Palsy/facial paralysis*,453,148,47,1,649,1.10,1.02,1.68,1.11
2021-11-12,2021-11-19,Nerves and central nervous system,Cerebrovascular accident (stroke),91,32,34,3,160,0.22,0.22,1.22,0.27
2021-11-12,2021-11-19,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),22,8,5,0,35,0.05,0.06,0.18,0.06
2021-11-12,2021-11-19,Nerves and central nervous system,Subtotal n (%),566,188,86,4,844,1.37,1.30,3.08,1.44
2021-11-12,2021-11-19,Other system,Anaphylaxis*,464,128,22,1,615,1.12,0.88,0.79,1.05
2021-11-12,2021-11-19,Other system,COVID-19*,137,7,1,10,155,0.33,0.05,0.04,0.26
2021-11-12,2021-11-19,Other system,Multisystem inflammatory syndrome,4,1,0,0,5,0.01,0.01,0.00,0.01
2021-11-12,2021-11-19,Other system,Subtotal n (%),605,136,23,11,775,1.46,0.94,0.82,1.32
2021-11-12,2021-11-19,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-11-12,2021-11-19,Pregnancy outcomes,Spontaneous abortion,42,9,1,0,52,0.10,0.06,0.04,0.09
2021-11-12,2021-11-19,Pregnancy outcomes,Subtotal n (%),47,9,1,0,57,0.11,0.06,0.04,0.10
2021-11-12,2021-11-19,Respiratory system,Acute respiratory distress syndrome,2,2,0,0,4,0.00,0.01,0.00,0.01
2021-11-12,2021-11-19,Respiratory system,Subtotal n (%),2,2,0,0,4,0.00,0.01,0.00,0.01
2021-11-12,2021-11-19,"Skin and mucous membrane, bone and joints system",Chilblains,10,3,1,0,14,0.02,0.02,0.04,0.02
2021-11-12,2021-11-19,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),19,10,1,0,30,0.05,0.07,0.04,0.05
2021-11-12,2021-11-19,"Skin and mucous membrane, bone and joints system",Subtotal n (%),29,13,2,0,44,0.07,0.09,0.07,0.08
2021-11-12,2021-11-19,All AESI categories,TOTAL,2721,1046,593,30,4390,6.59,7.23,21.20,7.49
2021-11-19,2021-11-26,Auto-immune diseases,Guillain-Barré Syndrome,44,22,37,0,103,0.11,0.15,1.32,0.17
2021-11-19,2021-11-26,Auto-immune diseases,Thrombocytopenia (low blood platelets),23,10,40,3,76,0.06,0.07,1.43,0.13
2021-11-19,2021-11-26,Auto-immune diseases,Subtotal n (%),67,32,77,3,179,0.16,0.22,2.75,0.30
2021-11-19,2021-11-26,Cardiovascular system,Cardiac arrest,19,12,5,0,36,0.05,0.08,0.18,0.06
2021-11-19,2021-11-26,Cardiovascular system,Cardiac failure,22,9,4,1,36,0.05,0.06,0.14,0.06
2021-11-19,2021-11-26,Cardiovascular system,Myocardial infarction (heart attack),61,20,6,3,90,0.15,0.14,0.21,0.15
2021-11-19,2021-11-26,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),823,479,24,3,1329,1.98,3.27,0.86,2.25
2021-11-19,2021-11-26,Cardiovascular system,Subtotal n (%),925,520,39,7,1491,2.22,3.55,1.39,2.52
2021-11-19,2021-11-26,Circulatory system,Cerebral venous (sinus) thrombosis,3,1,11,0,15,0.01,0.01,0.39,0.03
2021-11-19,2021-11-26,Circulatory system,Cerebral thrombosis ,6,4,1,0,11,0.01,0.03,0.04,0.02
2021-11-19,2021-11-26,Circulatory system,Cutaneous vasculitis,16,7,4,0,27,0.04,0.05,0.14,0.05
2021-11-19,2021-11-26,Circulatory system,Deep vein thrombosis,127,44,61,0,232,0.30,0.30,2.18,0.39
2021-11-19,2021-11-26,Circulatory system,Embolism,3,3,6,0,12,0.01,0.02,0.21,0.02
2021-11-19,2021-11-26,Circulatory system,Haemorrhage (bleeding),31,10,8,2,51,0.07,0.07,0.29,0.09
2021-11-19,2021-11-26,Circulatory system,Pulmonary embolism,173,65,116,0,354,0.42,0.44,4.15,0.60
2021-11-19,2021-11-26,Circulatory system,Thrombosis (blood clot),120,27,85,2,234,0.29,0.18,3.04,0.40
2021-11-19,2021-11-26,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),19,6,64,0,89,0.05,0.04,2.29,0.15
2021-11-19,2021-11-26,Circulatory system,Subtotal n (%),498,167,356,4,1025,1.20,1.14,12.73,1.73
2021-11-19,2021-11-26,Hepato-gastrointestinal and renal system,Acute kidney injury,23,14,4,0,41,0.06,0.10,0.14,0.07
2021-11-19,2021-11-26,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),6,2,0,0,8,0.01,0.01,0.00,0.01
2021-11-19,2021-11-26,Hepato-gastrointestinal and renal system,Liver injury,16,8,3,0,27,0.04,0.05,0.11,0.05
2021-11-19,2021-11-26,Hepato-gastrointestinal and renal system,Subtotal n (%),45,24,7,0,76,0.11,0.16,0.25,0.13
2021-11-19,2021-11-26,Nerves and central nervous system,Bell's Palsy/facial paralysis*,455,150,47,1,653,1.09,1.02,1.68,1.10
2021-11-19,2021-11-26,Nerves and central nervous system,Cerebrovascular accident (stroke),96,33,34,3,166,0.23,0.23,1.22,0.28
2021-11-19,2021-11-26,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),23,8,5,0,36,0.06,0.05,0.18,0.06
2021-11-19,2021-11-26,Nerves and central nervous system,Subtotal n (%),574,191,86,4,855,1.38,1.30,3.07,1.45
2021-11-19,2021-11-26,Other system,Anaphylaxis*,488,131,23,1,643,1.17,0.89,0.82,1.09
2021-11-19,2021-11-26,Other system,COVID-19*,138,6,1,11,156,0.33,0.04,0.04,0.26
2021-11-19,2021-11-26,Other system,Multisystem inflammatory syndrome,4,1,0,0,5,0.01,0.01,0.00,0.01
2021-11-19,2021-11-26,Other system,Subtotal n (%),630,138,24,12,804,1.51,0.94,0.86,1.36
2021-11-19,2021-11-26,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-11-19,2021-11-26,Pregnancy outcomes,Spontaneous abortion,43,10,1,0,54,0.10,0.07,0.04,0.09
2021-11-19,2021-11-26,Pregnancy outcomes,Subtotal n (%),48,10,1,0,59,0.12,0.07,0.04,0.10
2021-11-19,2021-11-26,Respiratory system,Acute respiratory distress syndrome,2,2,0,0,4,0.00,0.01,0.00,0.01
2021-11-19,2021-11-26,Respiratory system,Subtotal n (%),2,2,0,0,4,0.00,0.01,0.00,0.01
2021-11-19,2021-11-26,"Skin and mucous membrane, bone and joints system",Chilblains,11,3,1,0,15,0.03,0.02,0.04,0.03
2021-11-19,2021-11-26,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),20,10,1,0,31,0.05,0.07,0.04,0.05
2021-11-19,2021-11-26,"Skin and mucous membrane, bone and joints system",Subtotal n (%),31,13,2,0,46,0.07,0.09,0.07,0.08
2021-11-19,2021-11-26,All AESI categories,TOTAL,2820,1097,592,30,4539,6.77,7.49,21.16,7.67
2021-11-26,2021-12-03,Auto-immune diseases,Guillain-Barré Syndrome,44,22,37,0,103,0.10,0.15,1.32,0.17
2021-11-26,2021-12-03,Auto-immune diseases,Thrombocytopenia (low blood platelets),19,9,40,3,71,0.05,0.06,1.43,0.12
2021-11-26,2021-12-03,Auto-immune diseases,Subtotal n (%),63,31,77,3,174,0.15,0.21,2.75,0.29
2021-11-26,2021-12-03,Cardiovascular system,Cardiac arrest,19,12,5,0,36,0.05,0.08,0.18,0.06
2021-11-26,2021-12-03,Cardiovascular system,Cardiac failure,23,9,4,1,37,0.05,0.06,0.14,0.06
2021-11-26,2021-12-03,Cardiovascular system,Myocardial infarction (heart attack),65,20,6,3,94,0.15,0.14,0.21,0.16
2021-11-26,2021-12-03,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),853,495,25,3,1376,2.03,3.37,0.89,2.31
2021-11-26,2021-12-03,Cardiovascular system,Subtotal n (%),960,536,40,7,1543,2.28,3.64,1.43,2.59
2021-11-26,2021-12-03,Circulatory system,Cerebral venous (sinus) thrombosis,4,1,12,0,17,0.01,0.01,0.43,0.03
2021-11-26,2021-12-03,Circulatory system,Cerebral thrombosis,6,4,1,0,11,0.01,0.03,0.04,0.02
2021-11-26,2021-12-03,Circulatory system,Cutaneous vasculitis,14,8,6,0,28,0.03,0.05,0.21,0.05
2021-11-26,2021-12-03,Circulatory system,Deep vein thrombosis,132,45,61,0,238,0.31,0.31,2.18,0.40
2021-11-26,2021-12-03,Circulatory system,Embolism,3,3,6,0,12,0.01,0.02,0.21,0.02
2021-11-26,2021-12-03,Circulatory system,Haemorrhage (bleeding),31,11,8,2,52,0.07,0.07,0.29,0.09
2021-11-26,2021-12-03,Circulatory system,Pulmonary embolism,177,66,116,0,359,0.42,0.45,4.15,0.60
2021-11-26,2021-12-03,Circulatory system,Thrombosis (blood clot),125,27,85,2,239,0.30,0.18,3.04,0.40
2021-11-26,2021-12-03,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets),19,6,64,0,89,0.05,0.04,2.29,0.15
2021-11-26,2021-12-03,Circulatory system,Subtotal n (%),511,171,359,4,1045,1.22,1.16,12.83,1.75
2021-11-26,2021-12-03,Hepato-gastrointestinal and renal system,Acute kidney injury,24,14,4,0,42,0.06,0.10,0.14,0.07
2021-11-26,2021-12-03,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),6,2,0,0,8,0.01,0.01,0.00,0.01
2021-11-26,2021-12-03,Hepato-gastrointestinal and renal system,Liver injury,16,8,3,0,27,0.04,0.05,0.11,0.05
2021-11-26,2021-12-03,Hepato-gastrointestinal and renal system,Subtotal n (%),46,24,7,0,77,0.11,0.16,0.25,0.13
2021-11-26,2021-12-03,Nerves and central nervous system,Bell's Palsy/facial paralysis*,462,152,48,1,663,1.10,1.03,1.72,1.11
2021-11-26,2021-12-03,Nerves and central nervous system,Cerebrovascular accident (stroke),98,35,34,3,170,0.23,0.24,1.22,0.29
2021-11-26,2021-12-03,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),24,7,5,0,36,0.06,0.05,0.18,0.06
2021-11-26,2021-12-03,Nerves and central nervous system,Subtotal n (%),584,194,87,4,869,1.39,1.32,3.11,1.46
2021-11-26,2021-12-03,Other system,Anaphylaxis*,505,141,24,1,671,1.20,0.96,0.86,1.13
2021-11-26,2021-12-03,Other system,COVID-19*,141,7,1,11,160,0.34,0.05,0.04,0.27
2021-11-26,2021-12-03,Other system,Multisystem inflammatory syndrome,4,1,0,0,5,0.01,0.01,0.00,0.01
2021-11-26,2021-12-03,Other system,Subtotal n (%),650,149,25,12,836,1.55,1.01,0.89,1.40
2021-11-26,2021-12-03,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-11-26,2021-12-03,Pregnancy outcomes,Spontaneous abortion,45,10,1,0,56,0.11,0.07,0.04,0.09
2021-11-26,2021-12-03,Pregnancy outcomes,Subtotal n (%),50,10,1,0,61,0.12,0.07,0.04,0.10
2021-11-26,2021-12-03,Respiratory system,Acute respiratory distress syndrome,2,2,0,0,4,0.00,0.01,0.00,0.01
2021-11-26,2021-12-03,Respiratory system,Subtotal n (%),2,2,0,0,4,0.00,0.01,0.00,0.01
2021-11-26,2021-12-03,"Skin and mucous membrane, bone and joints system",Chilblains,11,3,1,0,15,0.03,0.02,0.04,0.03
2021-11-26,2021-12-03,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),21,10,1,0,32,0.05,0.07,0.04,0.05
2021-11-26,2021-12-03,"Skin and mucous membrane, bone and joints system",Subtotal n (%),32,13,2,0,47,0.08,0.09,0.07,0.08
2021-11-26,2021-12-03,All AESI categories,TOTAL,2898,1130,598,30,4656,6.89,7.68,21.37,7.81
2021-12-03,2021-12-10,Auto-immune diseases,Guillain-Barré Syndrome,47,22,37,0,106,0.11,0.15,1.32,0.18
2021-12-03,2021-12-10,Auto-immune diseases,Thrombocytopenia (low blood platelets),19,9,39,3,70,0.05,0.06,1.39,0.12
2021-12-03,2021-12-10,Auto-immune diseases,Subtotal n (%),66,31,76,3,176,0.16,0.21,2.72,0.30
2021-12-03,2021-12-10,Cardiovascular system,Cardiac arrest,20,13,6,0,39,0.05,0.09,0.21,0.07
2021-12-03,2021-12-10,Cardiovascular system,Cardiac failure,23,10,4,1,38,0.05,0.07,0.14,0.06
2021-12-03,2021-12-10,Cardiovascular system,Myocardial infarction (heart attack),64,20,6,3,93,0.15,0.14,0.21,0.16
2021-12-03,2021-12-10,Cardiovascular system,Myocarditis/Pericarditis (inflammation of the heart muscle and lining around the heart),887,510,27,4,1428,2.11,3.47,0.96,2.40
2021-12-03,2021-12-10,Cardiovascular system,Subtotal n (%),994,553,43,8,1598,2.36,3.76,1.54,2.68
2021-12-03,2021-12-10,Circulatory system,Cerebral venous (sinus) thrombosis,4,1,11,0,16,0.01,0.01,0.39,0.03
2021-12-03,2021-12-10,Circulatory system,Cerebral thrombosis,6,4,1,0,11,0.01,0.03,0.04,0.02
2021-12-03,2021-12-10,Circulatory system,Cutaneous vasculitis,15,8,7,0,30,0.04,0.05,0.25,0.05
2021-12-03,2021-12-10,Circulatory system,Deep vein thrombosis,131,47,63,0,241,0.31,0.32,2.25,0.40
2021-12-03,2021-12-10,Circulatory system,Embolism,4,3,6,0,13,0.01,0.02,0.21,0.02
2021-12-03,2021-12-10,Circulatory system,Haemorrhage (bleeding),31,11,8,2,52,0.07,0.07,0.29,0.09
2021-12-03,2021-12-10,Circulatory system,Pulmonary embolism,181,66,117,0,364,0.43,0.45,4.18,0.61
2021-12-03,2021-12-10,Circulatory system,Thrombosis (blood clot),135,29,86,2,252,0.32,0.20,3.07,0.42
2021-12-03,2021-12-10,Circulatory system,Thrombosis with thrombocytopenia syndrome (blood clot with low platelets)*,19,6,64,0,89,0.05,0.04,2.29,0.15
2021-12-03,2021-12-10,Circulatory system,Subtotal n (%),526,175,363,4,1068,1.25,1.19,12.97,1.79
2021-12-03,2021-12-10,Hepato-gastrointestinal and renal system,Acute kidney injury,25,14,5,0,44,0.06,0.10,0.18,0.07
2021-12-03,2021-12-10,Hepato-gastrointestinal and renal system,Glomerulonephritis (kidney inflammation) and nephrotic syndrome (kidney disorder),7,2,1,0,10,0.02,0.01,0.04,0.02
2021-12-03,2021-12-10,Hepato-gastrointestinal and renal system,Liver injury,17,8,3,0,28,0.04,0.05,0.11,0.05
2021-12-03,2021-12-10,Hepato-gastrointestinal and renal system,Subtotal n (%),49,24,9,0,82,0.12,0.16,0.32,0.14
2021-12-03,2021-12-10,Nerves and central nervous system,Bell's Palsy/facial paralysis*,476,154,48,1,679,1.13,1.05,1.72,1.14
2021-12-03,2021-12-10,Nerves and central nervous system,Cerebrovascular accident (stroke),98,36,34,3,171,0.23,0.24,1.22,0.29
2021-12-03,2021-12-10,Nerves and central nervous system,Transverse myelitis (inflammation of spinal cord),25,8,5,0,38,0.06,0.05,0.18,0.06
2021-12-03,2021-12-10,Nerves and central nervous system,Subtotal n (%),599,198,87,4,888,1.43,1.35,3.11,1.49
2021-12-03,2021-12-10,Other system,Anaphylaxis*,514,143,25,1,683,1.22,0.97,0.89,1.15
2021-12-03,2021-12-10,Other system,COVID-19*,143,7,1,12,163,0.34,0.05,0.04,0.27
2021-12-03,2021-12-10,Other system,Multisystem inflammatory syndrome,5,1,0,0,6,0.01,0.01,0.00,0.01
2021-12-03,2021-12-10,Other system,Subtotal n (%),662,151,26,13,852,1.57,1.03,0.93,1.43
2021-12-03,2021-12-10,Pregnancy outcomes,Fetal growth restriction,5,0,0,0,5,0.01,0.00,0.00,0.01
2021-12-03,2021-12-10,Pregnancy outcomes,Spontaneous abortion,46,10,1,0,57,0.11,0.07,0.04,0.10
2021-12-03,2021-12-10,Pregnancy outcomes,Subtotal n (%),51,10,1,0,62,0.12,0.07,0.04,0.10
2021-12-03,2021-12-10,Respiratory system,Acute respiratory distress syndrome,2,2,0,0,4,0.00,0.01,0.00,0.01
2021-12-03,2021-12-10,Respiratory system,Subtotal n (%),2,2,0,0,4,0.00,0.01,0.00,0.01
2021-12-03,2021-12-10,"Skin and mucous membrane, bone and joints system",Chilblains,11,4,1,0,16,0.03,0.03,0.04,0.03
2021-12-03,2021-12-10,"Skin and mucous membrane, bone and joints system",Erythema multiforme (immune skin reaction),22,10,1,0,33,0.05,0.07,0.04,0.06
2021-12-03,2021-12-10,"Skin and mucous membrane, bone and joints system",Subtotal n (%),33,14,2,0,49,0.08,0.10,0.07,0.08
2021-12-03,2021-12-10,All AESI categories,TOTAL,2982,1158,607,32,4779,7.09,7.87,21.69,8.02